drksid,version_number,total_versions,version_date,recruitment_status,start_date,closing_date,enrolment,enrolment_type,min_age,max_age,gender,inclusion_criteria,exclusion_criteria,primary_outcomes,secondary_outcomes,contacts
DRKS00003246,1,9,2013-05-31,Recruiting planned,2013-06-02,NA,60,Planned,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003246,2,9,2013-08-29,Recruiting planned,2013-09-03,NA,60,Planned,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003246,3,9,2013-10-10,Recruiting planned,2013-10-11,NA,60,Planned,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003246,4,9,2013-12-05,Recruiting ongoing,2013-10-23,NA,60,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003246,5,9,2014-05-21,Recruiting ongoing,2013-10-23,NA,60,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003246,6,9,2015-09-15,Recruiting ongoing,2013-10-23,NA,60,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003246,7,9,2016-06-06,"Recruiting complete, follow-up continuing",2013-10-23,NA,60,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003246,8,9,2017-02-15,Recruiting stopped after recruiting started ,2013-10-23,2016-12-02,60,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003246,9,9,2017-08-04,Recruiting stopped after recruiting started ,2013-10-23,2016-12-02,60,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Clinical signs of radiation retinopathy (cotton wool spots, hemorrhages, vascular ischemia)\n\nVisual impairment due to focal or diffuse radiation induced macula edema (ME) in the irradiated eye that is eligible for laser treatment\n\nAge ≥18 years\n\nBCVA less than 20/32""]","[""Exclusion Criteria"",""Concomitant conditions in the study eye which could, in the opinion of the investigator, prevent VA improvement, e.g. tumor recurrence, tumor growth underneath the macula\n\nEndoresection and / or previous vitrectomy\n\nPatients with proliferative retinopathies or macular edema due to reasons other than irradiation: e.g. diabetic retinopathy, vein occlusion, or Irvine-Gass syndrome\n\nTreatment with anti-angiogenic drugs or intravitreal corticosteroids or any other investigational drug within 3 months prior to randomisation\n\nPrior laser photocoagulation treatment within 3 months (focal / grid laser) or 6 months (panretinal) prior to study entry\n\nKnown hypersensitivity against local anaesthetics\n\nKnown hypersensitivity against iodine""]","[""Change from baseline in BCVA (Best Corrected Visual Acuity) over 6 months (area under curve / 6 months)""]","[""Change from baseline in macular thickness and the size of areas of macular and peripheral capillary drop out over 6 months (area under the curve / 6 months)\n\nChange from baseline in BCVA, macular thickness and the size of areas of macular and peripheral capillary drop out over 12 months (area under the curve / 12 months)\n\nProportion of patients with improvement of visual acuity after 6 and 12 months\n\nRate of vitreous hemorrhages""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité University Medicine Berlin Department of Ophthalmology\nMs. Prof. Dr. med. Antonia Joussen \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin Department of Ophthalmology"",""Ms. Prof. Dr. med. Antonia Joussen "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: 030 450 554 202\nFax: [---]*\nE-mail: Antonia.Joussen at charite.de\nURL: [---]*"",""Telephone: 030 450 554 202"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Antonia.Joussen at charite.de"",""E-mail:"",""Antonia.Joussen at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité University Medicine Berlin, Department of Ophthalmology\nMs. Sabrina Thees \nHindenburgdamm 30\n12200 Berlin\nGermany"",""Charité University Medicine Berlin, Department of Ophthalmology"",""Ms. Sabrina Thees "",""Hindenburgdamm 30"",""12200 Berlin"",""Germany"",""Telephone: +49 30 450 654138\nFax: [---]*\nE-mail: Sabrina.Thees at charite.de\nURL: [---]*"",""Telephone: +49 30 450 654138"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: Sabrina.Thees at charite.de"",""E-mail:"",""Sabrina.Thees at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003568,1,7,2012-02-22,Recruiting ongoing,2011-11-30,NA,560,Actual,18 Years,80 Years,"Both, male and female","[""Additional Inclusion Criteria"",""After ACS, Bypass-OP, PCI.""]","[""Exclusion Criteria"",""Lack capacity to consent, lack of language skills.""]","[""Change and continuity in the areas of physical activity, dietary habits, smoking, mental health, compliance to medication. Self-reported questionnaire at begin, end of rehabilitation and follow-up at 6 and 12 month after the end of rehabilitation.""]","[""Regulation of blood pressure, blood glucose, blood cholesteron. Collection of clinical parameters at begin and end of rehabilitation. Self-reported questionnaire at begin and end of rehabilitation as well as follow-up at 6 and 12 month after end of rehabilitation.""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. Karla Spyra \nLuisenstraße 13A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. Karla Spyra "",""Luisenstraße 13A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 125\nFax: 030-4505 17 932\nE-mail: karla.spyra at charite.de\nURL: http://www.reha-vqs.charite.de/"",""Telephone: 030-4505 17 125"",""Telephone:"",""Fax: 030-4505 17 932"",""Fax:"",""E-mail: karla.spyra at charite.de"",""E-mail:"",""karla.spyra at charite.de"",""URL: http://www.reha-vqs.charite.de/"",""URL:"",""http://www.reha-vqs.charite.de/"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17 109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003568,2,7,2012-03-21,Recruiting ongoing,2011-11-30,NA,560,Actual,18 Years,80 Years,"Both, male and female","[""Additional Inclusion Criteria"",""After ACS, Bypass-OP, PCI.""]","[""Exclusion Criteria"",""Lack capacity to consent, lack of language skills.""]","[""Change and continuity in the areas of physical activity, dietary habits, smoking, mental health, compliance to medication. Self-reported questionnaire at begin, end of rehabilitation and follow-up at 6 and 12 month after the end of rehabilitation.""]","[""Regulation of blood pressure, blood glucose, blood cholesteron. Collection of clinical parameters at begin and end of rehabilitation. Self-reported questionnaire at begin and end of rehabilitation as well as follow-up at 6 and 12 month after end of rehabilitation.""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. Karla Spyra \nLuisenstraße 13A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. Karla Spyra "",""Luisenstraße 13A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 125\nFax: 030-4505 17 932\nE-mail: karla.spyra at charite.de\nURL: http://www.reha-vqs.charite.de/"",""Telephone: 030-4505 17 125"",""Telephone:"",""Fax: 030-4505 17 932"",""Fax:"",""E-mail: karla.spyra at charite.de"",""E-mail:"",""karla.spyra at charite.de"",""URL: http://www.reha-vqs.charite.de/"",""URL:"",""http://www.reha-vqs.charite.de/"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17 109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003568,3,7,2012-03-21,Recruiting ongoing,2011-11-30,NA,560,Actual,18 Years,80 Years,"Both, male and female","[""Additional Inclusion Criteria"",""After ACS, Bypass-OP, PCI.""]","[""Exclusion Criteria"",""Lack capacity to consent, lack of language skills.""]","[""Change and continuity in the areas of physical activity, dietary habits, smoking, mental health, compliance to medication. Self-reported questionnaire at begin, end of rehabilitation and follow-up at 6 and 12 month after the end of rehabilitation.""]","[""Regulation of blood pressure, blood glucose, blood cholesteron. Collection of clinical parameters at begin and end of rehabilitation. Self-reported questionnaire at begin and end of rehabilitation as well as follow-up at 6 and 12 month after end of rehabilitation.""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. Karla Spyra \nLuisenstraße 13A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. Karla Spyra "",""Luisenstraße 13A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 125\nFax: 030-4505 17 932\nE-mail: karla.spyra at charite.de\nURL: http://www.reha-vqs.charite.de/"",""Telephone: 030-4505 17 125"",""Telephone:"",""Fax: 030-4505 17 932"",""Fax:"",""E-mail: karla.spyra at charite.de"",""E-mail:"",""karla.spyra at charite.de"",""URL: http://www.reha-vqs.charite.de/"",""URL:"",""http://www.reha-vqs.charite.de/"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17 109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003568,4,7,2014-04-03,"Recruiting complete, follow-up continuing",2011-11-30,NA,560,Actual,18 Years,80 Years,"Both, male and female","[""Additional Inclusion Criteria"",""After ACS, Bypass-OP, PCI.""]","[""Exclusion Criteria"",""Lack capacity to consent, lack of language skills.""]","[""Change and continuity in the areas of physical activity, dietary habits, smoking, mental health, compliance to medication. Self-reported questionnaire at begin, end of rehabilitation and follow-up at 6 and 12 month after the end of rehabilitation.""]","[""Regulation of blood pressure, blood glucose, blood cholesteron. Collection of clinical parameters at begin and end of rehabilitation. Self-reported questionnaire at begin and end of rehabilitation as well as follow-up at 6 and 12 month after end of rehabilitation.""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. Karla Spyra \nLuisenstraße 13A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. Karla Spyra "",""Luisenstraße 13A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 125\nFax: 030-4505 17 932\nE-mail: karla.spyra at charite.de\nURL: http://www.reha-vqs.charite.de/"",""Telephone: 030-4505 17 125"",""Telephone:"",""Fax: 030-4505 17 932"",""Fax:"",""E-mail: karla.spyra at charite.de"",""E-mail:"",""karla.spyra at charite.de"",""URL: http://www.reha-vqs.charite.de/"",""URL:"",""http://www.reha-vqs.charite.de/"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17 109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003568,5,7,2015-11-06,"Recruiting complete, follow-up continuing",2011-11-30,NA,560,Actual,18 Years,80 Years,"Both, male and female","[""Additional Inclusion Criteria"",""After ACS, Bypass-OP, PCI.""]","[""Exclusion Criteria"",""Lack capacity to consent, lack of language skills.""]","[""Change and continuity in the areas of physical activity, dietary habits, smoking, mental health, compliance to medication. Self-reported questionnaire at begin, end of rehabilitation and follow-up at 6 and 12 month after the end of rehabilitation.""]","[""Regulation of blood pressure, blood glucose, blood cholesteron. Collection of clinical parameters at begin and end of rehabilitation. Self-reported questionnaire at begin and end of rehabilitation as well as follow-up at 6 and 12 month after end of rehabilitation.""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. Karla Spyra \nLuisenstraße 13A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. Karla Spyra "",""Luisenstraße 13A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 125\nFax: 030-4505 17 932\nE-mail: karla.spyra at charite.de\nURL: http://www.reha-vqs.charite.de/"",""Telephone: 030-4505 17 125"",""Telephone:"",""Fax: 030-4505 17 932"",""Fax:"",""E-mail: karla.spyra at charite.de"",""E-mail:"",""karla.spyra at charite.de"",""URL: http://www.reha-vqs.charite.de/"",""URL:"",""http://www.reha-vqs.charite.de/"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17 109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003568,6,7,2015-11-06,"Recruiting complete, follow-up complete",2011-11-30,2014-12-31,560,Actual,18 Years,80 Years,"Both, male and female","[""Additional Inclusion Criteria"",""After ACS, Bypass-OP, PCI.""]","[""Exclusion Criteria"",""Lack capacity to consent, lack of language skills.""]","[""Change and continuity in the areas of physical activity, dietary habits, smoking, mental health, compliance to medication. Self-reported questionnaire at begin, end of rehabilitation and follow-up at 6 and 12 month after the end of rehabilitation.""]","[""Regulation of blood pressure, blood glucose, blood cholesteron. Collection of clinical parameters at begin and end of rehabilitation. Self-reported questionnaire at begin and end of rehabilitation as well as follow-up at 6 and 12 month after end of rehabilitation.""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. Karla Spyra \nLuisenstraße 13A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. Karla Spyra "",""Luisenstraße 13A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 125\nFax: 030-4505 17 932\nE-mail: karla.spyra at charite.de\nURL: http://www.reha-vqs.charite.de/"",""Telephone: 030-4505 17 125"",""Telephone:"",""Fax: 030-4505 17 932"",""Fax:"",""E-mail: karla.spyra at charite.de"",""E-mail:"",""karla.spyra at charite.de"",""URL: http://www.reha-vqs.charite.de/"",""URL:"",""http://www.reha-vqs.charite.de/"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17 109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00003568,7,7,2016-11-09,"Recruiting complete, follow-up complete",2011-11-30,2014-12-31,560,Actual,18 Years,80 Years,"Both, male and female","[""Additional Inclusion Criteria"",""After ACS, Bypass-OP, PCI.""]","[""Exclusion Criteria"",""Lack capacity to consent, lack of language skills.""]","[""Change and continuity in the areas of physical activity, dietary habits, smoking, mental health, compliance to medication. Self-reported questionnaire at begin, end of rehabilitation and follow-up at 6 and 12 month after the end of rehabilitation.""]","[""Regulation of blood pressure, blood glucose, blood cholesteron. Collection of clinical parameters at begin and end of rehabilitation. Self-reported questionnaire at begin and end of rehabilitation as well as follow-up at 6 and 12 month after end of rehabilitation.""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. Karla Spyra \nLuisenstraße 13A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. Karla Spyra "",""Luisenstraße 13A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 125\nFax: 030-4505 17 932\nE-mail: karla.spyra at charite.de\nURL: http://www.reha-vqs.charite.de/"",""Telephone: 030-4505 17 125"",""Telephone:"",""Fax: 030-4505 17 932"",""Fax:"",""E-mail: karla.spyra at charite.de"",""E-mail:"",""karla.spyra at charite.de"",""URL: http://www.reha-vqs.charite.de/"",""URL:"",""http://www.reha-vqs.charite.de/"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung\nMs. Dr. med. Sabine Stamm-Balderjahn \nLuisenstraße 13 A\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Lehrstuhl für Versorgungssystemforschung"",""Ms. Dr. med. Sabine Stamm-Balderjahn "",""Luisenstraße 13 A"",""10117 Berlin"",""Germany"",""Telephone: 030-4505 17 109\nFax: [---]*\nE-mail: sabine.stamm-balderjahn at charite.de\nURL: [---]*"",""Telephone: 030-4505 17 109"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: sabine.stamm-balderjahn at charite.de"",""E-mail:"",""sabine.stamm-balderjahn at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00004871,1,5,2013-04-26,Recruiting planned,2013-05-01,NA,44,Planned,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""-male and femal patient from 18 to 70 years old\n-existing, specialised physician (orthopedics, neurology, pain treatment) prooved diagnosis of chronic low back pain caused by nonspecific lumbar syndrome at least since 3 months\n- averaged pain intensity during the last 3 month of at least 40mm measured by VAS (visual analog scale) during pain periods on 4 out of 7 days a week""]","[""Exclusion Criteria"",""-anticoagulative treatment\n-anemia (Hgb in screening-lab below 12.2 g/dl bzw. 7.6 mmol/l\n(women); 14.0 g/dl bzw. 8.7 mmol/l (men)\n-anmenestic or laboratoric tested clotting disorder (Quick <70%, apTT >36 sec, TZ >21 sec)\n-invasive spine treatment including cortocoid injection up to 6 weeks ago or sheduled for the following 8 weeks\n-hemophilia\n-acute hernial disc\n-congenital spine disorders\n-known pregnancy or lactation\n-therapy by opioid-analgetics\n-insulin-dependent diabetes type 1\n-systemic medication by corticoids or immunisuppressives\n-acute psychotic disorders\n-serious comorbidity""]","[""global back pain on a 100mm VAS (visual analog scale) at day 28+-3\n""]","[""day 0:\n• general patients assuming concerning effectivenes and agreeability (Likert Skala)\n\nday 56±5:\n• VAS (100 mm) painscore (backpain)\n\nday 0, 28+-3, 56+-5:\n• 100 mm VAS scoring the average disability caused by back pain during the last week\n• Roland Morris Disability Questionnaire (RMDQ)\n• Functionial Questionarry of Back Pain (FFbH-R)\n• Quality of life SF36\n• mood, depression (CES-D)\n• affective pain assessment (SES)\n\nduring whole study period\n•intensity/frequency of pain medication (diary)""]","[""Primary Sponsor"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMr. Prof. Dr. med. Andreas Michalsen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Mr. Prof. Dr. med. Andreas Michalsen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 030 80505691\nFax: 03080505692\nE-mail: naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 030 80505691"",""Telephone:"",""Fax: 03080505692"",""Fax:"",""E-mail: naturheilkunde at immanuel.de"",""E-mail:"",""naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de"",""Contact for Scientific Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMr. Prof. Dr. med. Andreas Michalsen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Mr. Prof. Dr. med. Andreas Michalsen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 030 80505691\nFax: 03080505692\nE-mail: naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 030 80505691"",""Telephone:"",""Fax: 03080505692"",""Fax:"",""E-mail: naturheilkunde at immanuel.de"",""E-mail:"",""naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de"",""Contact for Public Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMs. Silke Hemmen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Ms. Silke Hemmen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 493080505682\nFax: 493080505692\nE-mail: studien.naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 493080505682"",""Telephone:"",""Fax: 493080505692"",""Fax:"",""E-mail: studien.naturheilkunde at immanuel.de"",""E-mail:"",""studien.naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de""]"
DRKS00004871,2,5,2013-04-26,Recruiting planned,2013-05-01,NA,44,Planned,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""-male and femal patient from 18 to 70 years old\n-existing, specialised physician (orthopedics, neurology, pain treatment) prooved diagnosis of chronic low back pain caused by nonspecific lumbar syndrome at least since 3 months\n- averaged pain intensity during the last 3 month of at least 40mm measured by VAS (visual analog scale) during pain periods on 4 out of 7 days a week""]","[""Exclusion Criteria"",""-anticoagulative treatment\n-anemia (Hgb in screening-lab below 12.2 g/dl bzw. 7.6 mmol/l\n(women); 14.0 g/dl bzw. 8.7 mmol/l (men)\n-anmenestic or laboratoric tested clotting disorder (Quick <70%, apTT >36 sec, TZ >21 sec)\n-invasive spine treatment including cortocoid injection up to 6 weeks ago or sheduled for the following 8 weeks\n-hemophilia\n-acute hernial disc\n-congenital spine disorders\n-known pregnancy or lactation\n-therapy by opioid-analgetics\n-insulin-dependent diabetes type 1\n-systemic medication by corticoids or immunisuppressives\n-acute psychotic disorders\n-serious comorbidity""]","[""global back pain on a 100mm VAS (visual analog scale) at day 28+-3\n""]","[""day 0:\n• general patients assuming concerning effectivenes and agreeability (Likert Skala)\n\nday 56±5:\n• VAS (100 mm) painscore (backpain)\n\nday 0, 28+-3, 56+-5:\n• 100 mm VAS scoring the average disability caused by back pain during the last week\n• Roland Morris Disability Questionnaire (RMDQ)\n• Functionial Questionarry of Back Pain (FFbH-R)\n• Quality of life SF36\n• mood, depression (CES-D)\n• affective pain assessment (SES)\n\nduring whole study period\n•intensity/frequency of pain medication (diary)""]","[""Primary Sponsor"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMr. Prof. Dr. med. Andreas Michalsen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Mr. Prof. Dr. med. Andreas Michalsen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 030 80505691\nFax: 03080505692\nE-mail: naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 030 80505691"",""Telephone:"",""Fax: 03080505692"",""Fax:"",""E-mail: naturheilkunde at immanuel.de"",""E-mail:"",""naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de"",""Contact for Scientific Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMr. Prof. Dr. med. Andreas Michalsen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Mr. Prof. Dr. med. Andreas Michalsen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 030 80505691\nFax: 03080505692\nE-mail: naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 030 80505691"",""Telephone:"",""Fax: 03080505692"",""Fax:"",""E-mail: naturheilkunde at immanuel.de"",""E-mail:"",""naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de"",""Contact for Public Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMs. Silke Hemmen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Ms. Silke Hemmen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 493080505682\nFax: 493080505692\nE-mail: studien.naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 493080505682"",""Telephone:"",""Fax: 493080505692"",""Fax:"",""E-mail: studien.naturheilkunde at immanuel.de"",""E-mail:"",""studien.naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de""]"
DRKS00004871,3,5,2013-10-25,Recruiting ongoing,2013-05-02,NA,44,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""-male and femal patient from 18 to 70 years old\n-existing, specialised physician (orthopedics, neurology, pain treatment) prooved diagnosis of chronic low back pain caused by nonspecific lumbar syndrome at least since 3 months\n- averaged pain intensity during the last 3 month of at least 40mm measured by VAS (visual analog scale) during pain periods on 4 out of 7 days a week""]","[""Exclusion Criteria"",""-anticoagulative treatment\n-anemia (Hgb in screening-lab below 12.2 g/dl bzw. 7.6 mmol/l\n(women); 14.0 g/dl bzw. 8.7 mmol/l (men)\n-anmenestic or laboratoric tested clotting disorder (Quick <70%, apTT >36 sec, TZ >21 sec)\n-invasive spine treatment including cortocoid injection up to 6 weeks ago or sheduled for the following 8 weeks\n-hemophilia\n-acute hernial disc\n-congenital spine disorders\n-known pregnancy or lactation\n-therapy by opioid-analgetics\n-insulin-dependent diabetes type 1\n-systemic medication by corticoids or immunisuppressives\n-acute psychotic disorders\n-serious comorbidity""]","[""global back pain on a 100mm VAS (visual analog scale) at day 28+-3\n""]","[""day 0:\n• general patients assuming concerning effectivenes and agreeability (Likert Skala)\n\nday 56±5:\n• VAS (100 mm) painscore (backpain)\n\nday 0, 28+-3, 56+-5:\n• 100 mm VAS scoring the average disability caused by back pain during the last week\n• Roland Morris Disability Questionnaire (RMDQ)\n• Functionial Questionarry of Back Pain (FFbH-R)\n• Quality of life SF36\n• mood, depression (CES-D)\n• affective pain assessment (SES)\n\nduring whole study period\n•intensity/frequency of pain medication (diary)""]","[""Primary Sponsor"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMr. Prof. Dr. med. Andreas Michalsen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Mr. Prof. Dr. med. Andreas Michalsen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 030 80505691\nFax: 03080505692\nE-mail: naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 030 80505691"",""Telephone:"",""Fax: 03080505692"",""Fax:"",""E-mail: naturheilkunde at immanuel.de"",""E-mail:"",""naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de"",""Contact for Scientific Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMr. Prof. Dr. med. Andreas Michalsen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Mr. Prof. Dr. med. Andreas Michalsen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 030 80505691\nFax: 03080505692\nE-mail: naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 030 80505691"",""Telephone:"",""Fax: 03080505692"",""Fax:"",""E-mail: naturheilkunde at immanuel.de"",""E-mail:"",""naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de"",""Contact for Public Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMs. Silke Hemmen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Ms. Silke Hemmen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 493080505682\nFax: 493080505692\nE-mail: studien.naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 493080505682"",""Telephone:"",""Fax: 493080505692"",""Fax:"",""E-mail: studien.naturheilkunde at immanuel.de"",""E-mail:"",""studien.naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de""]"
DRKS00004871,4,5,2016-04-11,"Recruiting complete, follow-up complete",2013-05-02,2015-12-14,44,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""-male and femal patient from 18 to 70 years old\n-existing, specialised physician (orthopedics, neurology, pain treatment) prooved diagnosis of chronic low back pain caused by nonspecific lumbar syndrome at least since 3 months\n- averaged pain intensity during the last 3 month of at least 40mm measured by VAS (visual analog scale) during pain periods on 4 out of 7 days a week""]","[""Exclusion Criteria"",""-anticoagulative treatment\n-anemia (Hgb in screening-lab below 12.2 g/dl bzw. 7.6 mmol/l\n(women); 14.0 g/dl bzw. 8.7 mmol/l (men)\n-anmenestic or laboratoric tested clotting disorder (Quick <70%, apTT >36 sec, TZ >21 sec)\n-invasive spine treatment including cortocoid injection up to 6 weeks ago or sheduled for the following 8 weeks\n-hemophilia\n-acute hernial disc\n-congenital spine disorders\n-known pregnancy or lactation\n-therapy by opioid-analgetics\n-insulin-dependent diabetes type 1\n-systemic medication by corticoids or immunisuppressives\n-acute psychotic disorders\n-serious comorbidity""]","[""global back pain on a 100mm VAS (visual analog scale) at day 28+-3\n""]","[""day 0:\n• general patients assuming concerning effectivenes and agreeability (Likert Skala)\n\nday 56±5:\n• VAS (100 mm) painscore (backpain)\n\nday 0, 28+-3, 56+-5:\n• 100 mm VAS scoring the average disability caused by back pain during the last week\n• Roland Morris Disability Questionnaire (RMDQ)\n• Functionial Questionarry of Back Pain (FFbH-R)\n• Quality of life SF36\n• mood, depression (CES-D)\n• affective pain assessment (SES)\n\nduring whole study period\n•intensity/frequency of pain medication (diary)""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030 450\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: 030 450"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMr. Prof. Dr. med. Andreas Michalsen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Mr. Prof. Dr. med. Andreas Michalsen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 030 80505691\nFax: 03080505692\nE-mail: naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 030 80505691"",""Telephone:"",""Fax: 03080505692"",""Fax:"",""E-mail: naturheilkunde at immanuel.de"",""E-mail:"",""naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de"",""Contact for Public Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMs. Silke Hemmen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Ms. Silke Hemmen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 493080505682\nFax: 493080505692\nE-mail: studien.naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 493080505682"",""Telephone:"",""Fax: 493080505692"",""Fax:"",""E-mail: studien.naturheilkunde at immanuel.de"",""E-mail:"",""studien.naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de""]"
DRKS00004871,5,5,2016-10-14,"Recruiting complete, follow-up complete",2013-05-02,2015-12-14,44,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""-male and femal patient from 18 to 70 years old\n-existing, specialised physician (orthopedics, neurology, pain treatment) prooved diagnosis of chronic low back pain caused by nonspecific lumbar syndrome at least since 3 months\n- averaged pain intensity during the last 3 month of at least 40mm measured by VAS (visual analog scale) during pain periods on 4 out of 7 days a week""]","[""Exclusion Criteria"",""-anticoagulative treatment\n-anemia (Hgb in screening-lab below 12.2 g/dl bzw. 7.6 mmol/l\n(women); 14.0 g/dl bzw. 8.7 mmol/l (men)\n-anmenestic or laboratoric tested clotting disorder (Quick <70%, apTT >36 sec, TZ >21 sec)\n-invasive spine treatment including cortocoid injection up to 6 weeks ago or sheduled for the following 8 weeks\n-hemophilia\n-acute hernial disc\n-congenital spine disorders\n-known pregnancy or lactation\n-therapy by opioid-analgetics\n-insulin-dependent diabetes type 1\n-systemic medication by corticoids or immunisuppressives\n-acute psychotic disorders\n-serious comorbidity""]","[""global back pain on a 100mm VAS (visual analog scale) at day 28+-3\n""]","[""day 0:\n• general patients assuming concerning effectivenes and agreeability (Likert Skala)\n\nday 56±5:\n• VAS (100 mm) painscore (backpain)\n\nday 0, 28+-3, 56+-5:\n• 100 mm VAS scoring the average disability caused by back pain during the last week\n• Roland Morris Disability Questionnaire (RMDQ)\n• Functionial Questionarry of Back Pain (FFbH-R)\n• Quality of life SF36\n• mood, depression (CES-D)\n• affective pain assessment (SES)\n\nduring whole study period\n•intensity/frequency of pain medication (diary)""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030 450\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: 030 450"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMr. Prof. Dr. med. Andreas Michalsen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Mr. Prof. Dr. med. Andreas Michalsen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 030 80505691\nFax: 03080505692\nE-mail: naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 030 80505691"",""Telephone:"",""Fax: 03080505692"",""Fax:"",""E-mail: naturheilkunde at immanuel.de"",""E-mail:"",""naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de"",""Contact for Public Queries"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin\nMs. Silke Hemmen \nKönigstr. 63\n14109 Berlin\nGermany"",""Hochschulambulanz für Naturheilkunde Charité-Universitätsmedizin Berlin"",""Ms. Silke Hemmen "",""Königstr. 63"",""14109 Berlin"",""Germany"",""Telephone: 493080505682\nFax: 493080505692\nE-mail: studien.naturheilkunde at immanuel.de\nURL: http://naturheilkunde.immanuel.de"",""Telephone: 493080505682"",""Telephone:"",""Fax: 493080505692"",""Fax:"",""E-mail: studien.naturheilkunde at immanuel.de"",""E-mail:"",""studien.naturheilkunde at immanuel.de"",""URL: http://naturheilkunde.immanuel.de"",""URL:"",""http://naturheilkunde.immanuel.de""]"
DRKS00007117,1,1,2014-11-05,"Recruiting complete, follow-up complete",2014-01-01,2014-10-01,200,Actual,18 Years,50 Years,Female,"[""Additional Inclusion Criteria"",""1. Age >18 years and fulfilling all criteria for a medically indicated need for CS. The indications\nare according to the guidelines of the German Society for Gynaecology and Obstetrics.\n2. Willing to be assigned to any of the study intervention groups\n3. Gestational age >37 weeks, patients without history of heavy peripartal bleeding, bleeding\ndisorders or other severe known maternal morbidities and known fetal anomalies.""]","[""Exclusion Criteria"",""1. preoperative change of consent from the parents\n2. heavy bleeding or other unexpected complications during CS and mechanical difficulty with the\nlift out of the babies head or breech.\n3. All fetuses with prenatal diagnosed anomalies which required an immediate treatment were\nexcluded (e.g. relevant congenital heart anomalies, closing defects of the abdominal wall,\ndiaphragmatic hernia).\n4. patients without written informed consent.""]","[""1. Perinatal safety: APGAR Scores. Admission to an intensive care unit. Cardiorespiratory\nproblems. Blood gas analysis umbilical cord (arterial pH value). Satisfaction with birth\n2. Mothers safety: cardiorespiratory disorders. Blood loss.\nModified Likert Scales were used to assess parameters of birth experience/satisfaction. Patients were asked with a standardized questionnaire between the second and fourth day after surgery.\n""]","[""1. Success rates of breast feeding.\n2. Problems with breast feeding.\n3. Conception of early-skin-to-skin contact.\n4. Complications of the attending partner.\nAgain Likert Scales were used. Also standardized questionnaire, given between 2nd and 4th day after birth.""]","[""Primary Sponsor"",""Klinik für Geburtsmedizin der Charité\nMr. Dr. med. Robert Armbrust \nAugustenburger Platz 1\n13352 Berlin\nGermany"",""Klinik für Geburtsmedizin der Charité"",""Mr. Dr. med. Robert Armbrust "",""Augustenburger Platz 1"",""13352 Berlin"",""Germany"",""Telephone: 030 450 664356\nFax: [---]*\nE-mail: robert.armbrust at charite,de\nURL: [---]*"",""Telephone: 030 450 664356"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: robert.armbrust at charite,de"",""E-mail:"",""robert.armbrust at charite,de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Klinik für Geburtsmedizin der Charité\nMr. Dr. med. Robert Armbrust \nAugustenburger Platz 1\n13352 Berlin\nGermany"",""Klinik für Geburtsmedizin der Charité"",""Mr. Dr. med. Robert Armbrust "",""Augustenburger Platz 1"",""13352 Berlin"",""Germany"",""Telephone: 030 450 664356\nFax: [---]*\nE-mail: robert.armbrust at charite,de\nURL: [---]*"",""Telephone: 030 450 664356"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: robert.armbrust at charite,de"",""E-mail:"",""robert.armbrust at charite,de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Klinik für Geburtsmedizin der Charité\nMr. Dr. med. Robert Armbrust \nAugustenburger Platz 1\n13352 Berlin\nGermany"",""Klinik für Geburtsmedizin der Charité"",""Mr. Dr. med. Robert Armbrust "",""Augustenburger Platz 1"",""13352 Berlin"",""Germany"",""Telephone: 030 450 664356\nFax: [---]*\nE-mail: robert.armbrust at charite,de\nURL: [---]*"",""Telephone: 030 450 664356"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: robert.armbrust at charite,de"",""E-mail:"",""robert.armbrust at charite,de"",""URL: [---]*"",""URL:""]"
DRKS00009347,1,6,2015-11-27,Recruiting ongoing,2015-09-23,NA,60,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- sex: male and female\n- minimum age: 18 years\n- maximum age: 70 years\n- healthy sleep (control group) or\npresence of one of the following diagnoses:\no restless legs syndrome\no obstructive sleep apnea\n- comprehension of the study protocol\n- written consent\n""]","[""Exclusion Criteria"",""- severe heart failure\n- severe respiratory failure\n- home ventilation (BiLevel or higher)\n- acute psychiatric disorder like severe depression, - mania or psychosis\n- body mass index > 40\n- pregnancy\ns- leep disorders (only relevant to control group)\n""]","[""Comparison of the data on night time movements that are collected with Video-KinectTM with the parameters of polysomnography regarding to depth of sleep, quality of sleep and sleep disturbance.""]","[""Compilation of a sleep profile (awake/sleep) based on the data of Kinect and comparison of these profile with the sleep profile that is calculated with polysomnography or actigraphy.""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030-450513122\nFax: 030-450513906\nE-mail: thomas.penzel at charite.de\nURL: http://schlafmedizin.charite.de"",""Telephone: 030-450513122"",""Telephone:"",""Fax: 030-450513906"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: http://schlafmedizin.charite.de"",""URL:"",""http://schlafmedizin.charite.de"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Dr. med. Christian Veauthier \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Dr. med. Christian Veauthier "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: +4930450513906\nE-mail: christian.veauthier at charite.de\nURL: http://schlafmedizin.charite.de"",""Telephone: +4930450513122"",""Telephone:"",""Fax: +4930450513906"",""Fax:"",""E-mail: christian.veauthier at charite.de"",""E-mail:"",""christian.veauthier at charite.de"",""URL: http://schlafmedizin.charite.de"",""URL:"",""http://schlafmedizin.charite.de""]"
DRKS00009347,2,6,2016-06-07,Recruiting ongoing,2015-09-23,NA,60,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- sex: male and female\n- minimum age: 18 years\n- maximum age: 70 years\n- healthy sleep (control group) or\npresence of one of the following diagnoses:\no restless legs syndrome\no obstructive sleep apnea\n- comprehension of the study protocol\n- written consent\n""]","[""Exclusion Criteria"",""- severe heart failure\n- severe respiratory failure\n- home ventilation (BiLevel or higher)\n- acute psychiatric disorder like severe depression, - mania or psychosis\n- body mass index > 40\n- pregnancy\ns- leep disorders (only relevant to control group)\n""]","[""Comparison of the data on night time movements that are collected with Video-KinectTM with the parameters of polysomnography regarding to depth of sleep, quality of sleep and sleep disturbance.""]","[""Compilation of a sleep profile (awake/sleep) based on the data of Kinect and comparison of these profile with the sleep profile that is calculated with polysomnography or actigraphy.""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030-450513122\nFax: 030-450513906\nE-mail: thomas.penzel at charite.de\nURL: http://schlafmedizin.charite.de"",""Telephone: 030-450513122"",""Telephone:"",""Fax: 030-450513906"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: http://schlafmedizin.charite.de"",""URL:"",""http://schlafmedizin.charite.de"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Dr. med. Christian Veauthier \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Dr. med. Christian Veauthier "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: +4930450513906\nE-mail: christian.veauthier at charite.de\nURL: http://schlafmedizin.charite.de"",""Telephone: +4930450513122"",""Telephone:"",""Fax: +4930450513906"",""Fax:"",""E-mail: christian.veauthier at charite.de"",""E-mail:"",""christian.veauthier at charite.de"",""URL: http://schlafmedizin.charite.de"",""URL:"",""http://schlafmedizin.charite.de""]"
DRKS00009347,3,6,2016-12-09,"Recruiting complete, follow-up complete",2015-09-23,2016-11-20,60,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- sex: male and female\n- minimum age: 18 years\n- maximum age: 70 years\n- healthy sleep (control group) or\npresence of one of the following diagnoses:\no restless legs syndrome\no obstructive sleep apnea\n- comprehension of the study protocol\n- written consent\n""]","[""Exclusion Criteria"",""- severe heart failure\n- severe respiratory failure\n- home ventilation (BiLevel or higher)\n- acute psychiatric disorder like severe depression, - mania or psychosis\n- body mass index > 40\n- pregnancy\ns- leep disorders (only relevant to control group)\n""]","[""Comparison of the data on night time movements that are collected with Video-KinectTM with the parameters of polysomnography regarding to depth of sleep, quality of sleep and sleep disturbance.""]","[""Compilation of a sleep profile (awake/sleep) based on the data of Kinect and comparison of these profile with the sleep profile that is calculated with polysomnography or actigraphy.""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030-450513122\nFax: 030-450513906\nE-mail: thomas.penzel at charite.de\nURL: http://schlafmedizin.charite.de"",""Telephone: 030-450513122"",""Telephone:"",""Fax: 030-450513906"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: http://schlafmedizin.charite.de"",""URL:"",""http://schlafmedizin.charite.de"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Dr. med. Christian Veauthier \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Dr. med. Christian Veauthier "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: +4930450513906\nE-mail: christian.veauthier at charite.de\nURL: https://schlafmedizin.charite.de"",""Telephone: +4930450513122"",""Telephone:"",""Fax: +4930450513906"",""Fax:"",""E-mail: christian.veauthier at charite.de"",""E-mail:"",""christian.veauthier at charite.de"",""URL: https://schlafmedizin.charite.de"",""URL:"",""https://schlafmedizin.charite.de""]"
DRKS00009347,4,6,2017-08-11,"Recruiting complete, follow-up complete",2015-09-23,2016-11-20,60,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- sex: male and female\n- minimum age: 18 years\n- maximum age: 70 years\n- healthy sleep (control group) or\npresence of one of the following diagnoses:\no restless legs syndrome\no obstructive sleep apnea\n- comprehension of the study protocol\n- written consent\n""]","[""Exclusion Criteria"",""- severe heart failure\n- severe respiratory failure\n- home ventilation (BiLevel or higher)\n- acute psychiatric disorder like severe depression, - mania or psychosis\n- body mass index > 40\n- pregnancy\ns- leep disorders (only relevant to control group)\n""]","[""Comparison of the data on night time movements that are collected with Video-KinectTM with the parameters of polysomnography regarding to depth of sleep, quality of sleep and sleep disturbance.""]","[""Compilation of a sleep profile (awake/sleep) based on the data of Kinect and comparison of these profile with the sleep profile that is calculated with polysomnography or actigraphy.""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030-450513122\nFax: 030-450513906\nE-mail: thomas.penzel at charite.de\nURL: http://schlafmedizin.charite.de"",""Telephone: 030-450513122"",""Telephone:"",""Fax: 030-450513906"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: http://schlafmedizin.charite.de"",""URL:"",""http://schlafmedizin.charite.de"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Dr. med. Christian Veauthier \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Dr. med. Christian Veauthier "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: +4930450513906\nE-mail: christian.veauthier at charite.de\nURL: https://schlafmedizin.charite.de"",""Telephone: +4930450513122"",""Telephone:"",""Fax: +4930450513906"",""Fax:"",""E-mail: christian.veauthier at charite.de"",""E-mail:"",""christian.veauthier at charite.de"",""URL: https://schlafmedizin.charite.de"",""URL:"",""https://schlafmedizin.charite.de""]"
DRKS00009347,5,6,2019-02-13,"Recruiting complete, follow-up complete",2015-09-23,2016-11-20,60,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- sex: male and female\n- minimum age: 18 years\n- maximum age: 70 years\n- healthy sleep (control group) or\npresence of one of the following diagnoses:\no restless legs syndrome\no obstructive sleep apnea\n- comprehension of the study protocol\n- written consent\n""]","[""Exclusion Criteria"",""- severe heart failure\n- severe respiratory failure\n- home ventilation (BiLevel or higher)\n- acute psychiatric disorder like severe depression, - mania or psychosis\n- body mass index > 40\n- pregnancy\ns- leep disorders (only relevant to control group)\n""]","[""Comparison of the data on night time movements that are collected with Video-KinectTM with the parameters of polysomnography regarding to depth of sleep, quality of sleep and sleep disturbance.""]","[""Compilation of a sleep profile (awake/sleep) based on the data of Kinect and comparison of these profile with the sleep profile that is calculated with polysomnography or actigraphy.""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030-450513122\nFax: 030-450513906\nE-mail: thomas.penzel at charite.de\nURL: http://schlafmedizin.charite.de"",""Telephone: 030-450513122"",""Telephone:"",""Fax: 030-450513906"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: http://schlafmedizin.charite.de"",""URL:"",""http://schlafmedizin.charite.de"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Dr. med. Christian Veauthier \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Dr. med. Christian Veauthier "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: +4930450513906\nE-mail: christian.veauthier at charite.de\nURL: https://schlafmedizin.charite.de"",""Telephone: +4930450513122"",""Telephone:"",""Fax: +4930450513906"",""Fax:"",""E-mail: christian.veauthier at charite.de"",""E-mail:"",""christian.veauthier at charite.de"",""URL: https://schlafmedizin.charite.de"",""URL:"",""https://schlafmedizin.charite.de""]"
DRKS00009347,6,6,2019-02-13,"Recruiting complete, follow-up complete",2015-09-23,2016-11-20,60,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- sex: male and female\n- minimum age: 18 years\n- maximum age: 70 years\n- healthy sleep (control group) or\npresence of one of the following diagnoses:\no restless legs syndrome\no obstructive sleep apnea\n- comprehension of the study protocol\n- written consent\n""]","[""Exclusion Criteria"",""- severe heart failure\n- severe respiratory failure\n- home ventilation (BiLevel or higher)\n- acute psychiatric disorder like severe depression, - mania or psychosis\n- body mass index > 40\n- pregnancy\ns- leep disorders (only relevant to control group)\n""]","[""Comparison of the data on night time movements that are collected with Video-KinectTM with the parameters of polysomnography regarding to depth of sleep, quality of sleep and sleep disturbance.""]","[""Compilation of a sleep profile (awake/sleep) based on the data of Kinect and comparison of these profile with the sleep profile that is calculated with polysomnography or actigraphy.""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Interdisziplinäres Schlafmedizinisches Zentrum Charité Universitätsmedizin Berlin"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030-450513122\nFax: 030-450513906\nE-mail: thomas.penzel at charite.de\nURL: http://schlafmedizin.charite.de"",""Telephone: 030-450513122"",""Telephone:"",""Fax: 030-450513906"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: http://schlafmedizin.charite.de"",""URL:"",""http://schlafmedizin.charite.de"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Dr. med. Christian Veauthier \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Dr. med. Christian Veauthier "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: +4930450513906\nE-mail: christian.veauthier at charite.de\nURL: https://schlafmedizin.charite.de"",""Telephone: +4930450513122"",""Telephone:"",""Fax: +4930450513906"",""Fax:"",""E-mail: christian.veauthier at charite.de"",""E-mail:"",""christian.veauthier at charite.de"",""URL: https://schlafmedizin.charite.de"",""URL:"",""https://schlafmedizin.charite.de""]"
DRKS00009368,1,5,2015-09-21,"Recruiting complete, follow-up complete",2015-03-11,2015-08-05,8,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""Patients eligible for inclusion were able to give informed consent, were between 18 and 95 years old and non-smokers (for ≥5 years). All patients wore removable prostheses, partially or totally covering the upper alveolar ridge and/or hard palate. Confirmation of diagnosis assumed from clinical signs of infection (at least in terms of erythematous maculae or zones but possibly hyperplasia or complaints as well) via Candida detection was required. Hence, all subjects were diagnosed with denture stomatitis Newton-level 1, 2 or 3 based on both positive clinical and paraclinical findings.""]","[""Exclusion Criteria"",""Patients having suffered from any malignant tumor within the last five years or suffering from severe general diseases (American Society of Anesthesiologists (ASA) risk class ≥ 3, myocardial infarction within the last six months, cardiomyopathy, New York Heart Association (NYHA) cardiac insufficiency stage ≥ III, chronic obstructive pulmonary disease (COPD), renal insufficiency, diabetes mellitus (HbA1c ≥ 7%), sickle-cell anemia, rheumatoid arthritis, status post radiation or organ transplantation, malnutrition) were excluded from the study. Furthermore, pacemaker carriers, pregnant women, smokers, alcoholics and drug users were not eligible.""]","[""At the end of treatment after six-time plasma application there is a remission of erythema. The evaluation is carried out using a digital measurement of the photographs made.""]","[""At the end of treatment after six-time plasma application Candida spp. can not or only sporadically be detected. A mouth swab confirms this. There is a reduction in VAS scores in cases with existing complaints. These are collected once a week.""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009368,2,5,2016-03-22,"Recruiting complete, follow-up complete",2015-03-11,2015-08-05,8,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""Patients eligible for inclusion were able to give informed consent, were between 18 and 95 years old and non-smokers (for ≥5 years). All patients wore removable prostheses, partially or totally covering the upper alveolar ridge and/or hard palate. Confirmation of diagnosis assumed from clinical signs of infection (at least in terms of erythematous maculae or zones but possibly hyperplasia or complaints as well) via Candida detection was required. Hence, all subjects were diagnosed with denture stomatitis Newton-level 1, 2 or 3 based on both positive clinical and paraclinical findings.""]","[""Exclusion Criteria"",""Patients having suffered from any malignant tumor within the last five years or suffering from severe general diseases (American Society of Anesthesiologists (ASA) risk class ≥ 3, myocardial infarction within the last six months, cardiomyopathy, New York Heart Association (NYHA) cardiac insufficiency stage ≥ III, chronic obstructive pulmonary disease (COPD), renal insufficiency, diabetes mellitus (HbA1c ≥ 7%), sickle-cell anemia, rheumatoid arthritis, status post radiation or organ transplantation, malnutrition) were excluded from the study. Furthermore, pacemaker carriers, pregnant women, smokers, alcoholics and drug users were not eligible.""]","[""At the end of treatment after six-time plasma application there is a remission of erythema. The evaluation is carried out using a digital measurement of the photographs made.""]","[""At the end of treatment after six-time plasma application Candida spp. can not or only sporadically be detected. A mouth swab confirms this. There is a reduction in VAS scores in cases with existing complaints. These are collected once a week.""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009368,3,5,2016-09-22,"Recruiting complete, follow-up complete",2015-03-11,2015-08-05,8,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""Patients eligible for inclusion were able to give informed consent, were between 18 and 95 years old and non-smokers (for ≥5 years). All patients wore removable prostheses, partially or totally covering the upper alveolar ridge and/or hard palate. Confirmation of diagnosis assumed from clinical signs of infection (at least in terms of erythematous maculae or zones but possibly hyperplasia or complaints as well) via Candida detection was required. Hence, all subjects were diagnosed with denture stomatitis Newton-level 1, 2 or 3 based on both positive clinical and paraclinical findings.""]","[""Exclusion Criteria"",""Patients having suffered from any malignant tumor within the last five years or suffering from severe general diseases (American Society of Anesthesiologists (ASA) risk class ≥ 3, myocardial infarction within the last six months, cardiomyopathy, New York Heart Association (NYHA) cardiac insufficiency stage ≥ III, chronic obstructive pulmonary disease (COPD), renal insufficiency, diabetes mellitus (HbA1c ≥ 7%), sickle-cell anemia, rheumatoid arthritis, status post radiation or organ transplantation, malnutrition) were excluded from the study. Furthermore, pacemaker carriers, pregnant women, smokers, alcoholics and drug users were not eligible.""]","[""At the end of treatment after six-time plasma application there is a remission of erythema. The evaluation is carried out using a digital measurement of the photographs made.""]","[""At the end of treatment after six-time plasma application Candida spp. can not or only sporadically be detected. A mouth swab confirms this. There is a reduction in VAS scores in cases with existing complaints. These are collected once a week.""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009368,4,5,2017-03-27,"Recruiting complete, follow-up complete",2015-03-11,2015-08-05,8,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""Patients eligible for inclusion were able to give informed consent, were between 18 and 95 years old and non-smokers (for ≥5 years). All patients wore removable prostheses, partially or totally covering the upper alveolar ridge and/or hard palate. Confirmation of diagnosis assumed from clinical signs of infection (at least in terms of erythematous maculae or zones but possibly hyperplasia or complaints as well) via Candida detection was required. Hence, all subjects were diagnosed with denture stomatitis Newton-level 1, 2 or 3 based on both positive clinical and paraclinical findings.""]","[""Exclusion Criteria"",""Patients having suffered from any malignant tumor within the last five years or suffering from severe general diseases (American Society of Anesthesiologists (ASA) risk class ≥ 3, myocardial infarction within the last six months, cardiomyopathy, New York Heart Association (NYHA) cardiac insufficiency stage ≥ III, chronic obstructive pulmonary disease (COPD), renal insufficiency, diabetes mellitus (HbA1c ≥ 7%), sickle-cell anemia, rheumatoid arthritis, status post radiation or organ transplantation, malnutrition) were excluded from the study. Furthermore, pacemaker carriers, pregnant women, smokers, alcoholics and drug users were not eligible.""]","[""At the end of treatment after six-time plasma application there is a remission of erythema. The evaluation is carried out using a digital measurement of the photographs made.""]","[""At the end of treatment after six-time plasma application Candida spp. can not or only sporadically be detected. A mouth swab confirms this. There is a reduction in VAS scores in cases with existing complaints. These are collected once a week.""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009368,5,5,2017-10-10,"Recruiting complete, follow-up complete",2015-03-11,2015-08-05,8,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""Patients eligible for inclusion were able to give informed consent, were between 18 and 95 years old and non-smokers (for ≥5 years). All patients wore removable prostheses, partially or totally covering the upper alveolar ridge and/or hard palate. Confirmation of diagnosis assumed from clinical signs of infection (at least in terms of erythematous maculae or zones but possibly hyperplasia or complaints as well) via Candida detection was required. Hence, all subjects were diagnosed with denture stomatitis Newton-level 1, 2 or 3 based on both positive clinical and paraclinical findings.""]","[""Exclusion Criteria"",""Patients having suffered from any malignant tumor within the last five years or suffering from severe general diseases (American Society of Anesthesiologists (ASA) risk class ≥ 3, myocardial infarction within the last six months, cardiomyopathy, New York Heart Association (NYHA) cardiac insufficiency stage ≥ III, chronic obstructive pulmonary disease (COPD), renal insufficiency, diabetes mellitus (HbA1c ≥ 7%), sickle-cell anemia, rheumatoid arthritis, status post radiation or organ transplantation, malnutrition) were excluded from the study. Furthermore, pacemaker carriers, pregnant women, smokers, alcoholics and drug users were not eligible.""]","[""At the end of treatment after six-time plasma application there is a remission of erythema. The evaluation is carried out using a digital measurement of the photographs made.""]","[""At the end of treatment after six-time plasma application Candida spp. can not or only sporadically be detected. A mouth swab confirms this. There is a reduction in VAS scores in cases with existing complaints. These are collected once a week.""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité Campus Benjamin Franklin; CC3 - Zahn-, Mund- und Kieferheilkunde"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009391,1,5,2016-01-08,"Recruiting complete, follow-up complete",2015-03-24,2016-01-07,20,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability (verbal, physically and mentally) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 95 years\n- Non-Smokers (for ≥ 5 years)\n- endentulous participants wearing complete dentures (incl. implant-assisted prostheses without signs of periimplant infections)\n\nSpecific inclusion criteria\nTest group (n=10)\n- confirmation of diagnosis assumed from clinical signs of candida infection\n- patients prior to antifungal therapy according to microbiological results\n\nControl group (n=10)\n- no signs of clinical symptoms of a candida infection""]","[""Exclusion Criteria"",""- Previous malignancies (≤5 years)\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, Diabetes mellitus with HbA1c ≥7.0%, ASA class ≥3)\n- Drug addiction, incl. Alcohol\n- smokers, ex-smokers < 5 years\n- Patients under 18 years old\n- Patients over 70 years\n- Participation in a similar study""]","[""Detectable Candida-specific signature VOCs (volatile organic compounds) at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable Candida-specific signature VOCs after antifungal therapy with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAßmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Aßmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin\nMr. Dr. Moritz Hertel \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Mr. Dr. Moritz Hertel "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450662626\nFax: [---]*\nE-mail: moritz.hertel at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450662626"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: moritz.hertel at charite.de"",""E-mail:"",""moritz.hertel at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009391,2,5,2016-03-22,"Recruiting complete, follow-up complete",2015-03-24,2016-01-07,20,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability (verbal, physically and mentally) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 95 years\n- Non-Smokers (for ≥ 5 years)\n- endentulous participants wearing complete dentures (incl. implant-assisted prostheses without signs of periimplant infections)\n\nSpecific inclusion criteria\nTest group (n=10)\n- confirmation of diagnosis assumed from clinical signs of candida infection\n- patients prior to antifungal therapy according to microbiological results\n\nControl group (n=10)\n- no signs of clinical symptoms of a candida infection""]","[""Exclusion Criteria"",""- Previous malignancies (≤5 years)\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, Diabetes mellitus with HbA1c ≥7.0%, ASA class ≥3)\n- Drug addiction, incl. Alcohol\n- smokers, ex-smokers < 5 years\n- Patients under 18 years old\n- Patients over 70 years\n- Participation in a similar study""]","[""Detectable Candida-specific signature VOCs (volatile organic compounds) at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable Candida-specific signature VOCs after antifungal therapy with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAßmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Aßmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin\nMr. Dr. Moritz Hertel \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Mr. Dr. Moritz Hertel "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450662626\nFax: [---]*\nE-mail: moritz.hertel at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450662626"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: moritz.hertel at charite.de"",""E-mail:"",""moritz.hertel at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009391,3,5,2016-09-22,"Recruiting complete, follow-up complete",2015-03-24,2016-01-07,20,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability (verbal, physically and mentally) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 95 years\n- Non-Smokers (for ≥ 5 years)\n- endentulous participants wearing complete dentures (incl. implant-assisted prostheses without signs of periimplant infections)\n\nSpecific inclusion criteria\nTest group (n=10)\n- confirmation of diagnosis assumed from clinical signs of candida infection\n- patients prior to antifungal therapy according to microbiological results\n\nControl group (n=10)\n- no signs of clinical symptoms of a candida infection""]","[""Exclusion Criteria"",""- Previous malignancies (≤5 years)\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, Diabetes mellitus with HbA1c ≥7.0%, ASA class ≥3)\n- Drug addiction, incl. Alcohol\n- smokers, ex-smokers < 5 years\n- Patients under 18 years old\n- Patients over 70 years\n- Participation in a similar study""]","[""Detectable Candida-specific signature VOCs (volatile organic compounds) at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable Candida-specific signature VOCs after antifungal therapy with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAßmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Aßmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin\nMr. Dr. Moritz Hertel \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Mr. Dr. Moritz Hertel "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450662626\nFax: [---]*\nE-mail: moritz.hertel at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450662626"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: moritz.hertel at charite.de"",""E-mail:"",""moritz.hertel at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009391,4,5,2017-03-27,"Recruiting complete, follow-up complete",2015-03-24,2016-01-07,20,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability (verbal, physically and mentally) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 95 years\n- Non-Smokers (for ≥ 5 years)\n- endentulous participants wearing complete dentures (incl. implant-assisted prostheses without signs of periimplant infections)\n\nSpecific inclusion criteria\nTest group (n=10)\n- confirmation of diagnosis assumed from clinical signs of candida infection\n- patients prior to antifungal therapy according to microbiological results\n\nControl group (n=10)\n- no signs of clinical symptoms of a candida infection""]","[""Exclusion Criteria"",""- Previous malignancies (≤5 years)\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, Diabetes mellitus with HbA1c ≥7.0%, ASA class ≥3)\n- Drug addiction, incl. Alcohol\n- smokers, ex-smokers < 5 years\n- Patients under 18 years old\n- Patients over 70 years\n- Participation in a similar study""]","[""Detectable Candida-specific signature VOCs (volatile organic compounds) at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable Candida-specific signature VOCs after antifungal therapy with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAßmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Aßmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin\nMr. Dr. Moritz Hertel \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Mr. Dr. Moritz Hertel "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450662626\nFax: [---]*\nE-mail: moritz.hertel at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450662626"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: moritz.hertel at charite.de"",""E-mail:"",""moritz.hertel at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009391,5,5,2017-10-09,"Recruiting complete, follow-up complete",2015-03-24,2016-01-07,20,Actual,18 Years,95 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability (verbal, physically and mentally) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 95 years\n- Non-Smokers (for ≥ 5 years)\n- endentulous participants wearing complete dentures (incl. implant-assisted prostheses without signs of periimplant infections)\n\nSpecific inclusion criteria\nTest group (n=10)\n- confirmation of diagnosis assumed from clinical signs of candida infection\n- patients prior to antifungal therapy according to microbiological results\n\nControl group (n=10)\n- no signs of clinical symptoms of a candida infection""]","[""Exclusion Criteria"",""- Previous malignancies (≤5 years)\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, Diabetes mellitus with HbA1c ≥7.0%, ASA class ≥3)\n- Drug addiction, incl. Alcohol\n- smokers, ex-smokers < 5 years\n- Patients under 18 years old\n- Patients over 70 years\n- Participation in a similar study""]","[""Detectable Candida-specific signature VOCs (volatile organic compounds) at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable Candida-specific signature VOCs after antifungal therapy with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAßmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Aßmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin\nMr. Dr. Moritz Hertel \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Mr. Dr. Moritz Hertel "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450662626\nFax: [---]*\nE-mail: moritz.hertel at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450662626"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: moritz.hertel at charite.de"",""E-mail:"",""moritz.hertel at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009539,1,5,2015-10-22,"Recruiting complete, follow-up complete",2014-11-19,2015-09-14,20,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability ( verbal , physically and mentally ) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 70 years\n- Karnofsky - Index : 80%\n- Smoking ( > 10 pack years , > 15 cigarettes / day )\n- Regular alcohol consumption ( < 50 g / week )\n\nTest group ( n = 15)\nSpecific inclusion criteria\n- Histologically confirmed primary PECA in the region of the oral cavity and oropharynx\n- Surgical treatment pending\n\nControl group ( n = 5)\nNo more than die inclusion criteria described above.\n\nPatients in both groups should be smokers and drink alcohol regularly to achieve a homogenous collective and in order to avoid overinterpretion of VOCs emitted through smoking/alcohol.""]","[""Exclusion Criteria"",""- Previous malignancies\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, not controlled diabetes)\n- HIV infection\n- Drug addiction\n- Patients under 18 years old\n- Patients over 70 years\n- Karnofsky Index : < 80 %\n- Participation in a similar study""]","[""Detectable tumor-specific signature VOCs at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable tumor-specific signature VOCs after surgery with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Virchow-Klinikum\nMr. Dr. med. Stefan Hartwig \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Campus Virchow-Klinikum"",""Mr. Dr. med. Stefan Hartwig "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +4939450655148\nFax: [---]*\nE-mail: stefan.hartwig at charite.de\nURL: http://www.charite.de"",""Telephone: +4939450655148"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: stefan.hartwig at charite.de"",""E-mail:"",""stefan.hartwig at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009539,2,5,2016-10-05,"Recruiting complete, follow-up complete",2014-11-19,2015-09-14,20,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability ( verbal , physically and mentally ) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 70 years\n- Karnofsky - Index : 80%\n- Smoking ( > 10 pack years , > 15 cigarettes / day )\n- Regular alcohol consumption ( < 50 g / week )\n\nTest group ( n = 15)\nSpecific inclusion criteria\n- Histologically confirmed primary PECA in the region of the oral cavity and oropharynx\n- Surgical treatment pending\n\nControl group ( n = 5)\nNo more than die inclusion criteria described above.\n\nPatients in both groups should be smokers and drink alcohol regularly to achieve a homogenous collective and in order to avoid overinterpretion of VOCs emitted through smoking/alcohol.""]","[""Exclusion Criteria"",""- Previous malignancies\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, not controlled diabetes)\n- HIV infection\n- Drug addiction\n- Patients under 18 years old\n- Patients over 70 years\n- Karnofsky Index : < 80 %\n- Participation in a similar study""]","[""Detectable tumor-specific signature VOCs at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable tumor-specific signature VOCs after surgery with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Virchow-Klinikum\nMr. Dr. med. Stefan Hartwig \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Campus Virchow-Klinikum"",""Mr. Dr. med. Stefan Hartwig "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +4939450655148\nFax: [---]*\nE-mail: stefan.hartwig at charite.de\nURL: http://www.charite.de"",""Telephone: +4939450655148"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: stefan.hartwig at charite.de"",""E-mail:"",""stefan.hartwig at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009539,3,5,2017-03-30,"Recruiting complete, follow-up complete",2014-11-19,2015-09-14,20,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability ( verbal , physically and mentally ) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 70 years\n- Karnofsky - Index : 80%\n- Smoking ( > 10 pack years , > 15 cigarettes / day )\n- Regular alcohol consumption ( < 50 g / week )\n\nTest group ( n = 15)\nSpecific inclusion criteria\n- Histologically confirmed primary PECA in the region of the oral cavity and oropharynx\n- Surgical treatment pending\n\nControl group ( n = 5)\nNo more than die inclusion criteria described above.\n\nPatients in both groups should be smokers and drink alcohol regularly to achieve a homogenous collective and in order to avoid overinterpretion of VOCs emitted through smoking/alcohol.""]","[""Exclusion Criteria"",""- Previous malignancies\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, not controlled diabetes)\n- HIV infection\n- Drug addiction\n- Patients under 18 years old\n- Patients over 70 years\n- Karnofsky Index : < 80 %\n- Participation in a similar study""]","[""Detectable tumor-specific signature VOCs at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable tumor-specific signature VOCs after surgery with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Virchow-Klinikum\nMr. Dr. med. Stefan Hartwig \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Campus Virchow-Klinikum"",""Mr. Dr. med. Stefan Hartwig "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +4939450655148\nFax: [---]*\nE-mail: stefan.hartwig at charite.de\nURL: http://www.charite.de"",""Telephone: +4939450655148"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: stefan.hartwig at charite.de"",""E-mail:"",""stefan.hartwig at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009539,4,5,2017-10-19,"Recruiting complete, follow-up complete",2014-11-19,2015-09-14,20,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability ( verbal , physically and mentally ) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 70 years\n- Karnofsky - Index : 80%\n- Smoking ( > 10 pack years , > 15 cigarettes / day )\n- Regular alcohol consumption ( < 50 g / week )\n\nTest group ( n = 15)\nSpecific inclusion criteria\n- Histologically confirmed primary PECA in the region of the oral cavity and oropharynx\n- Surgical treatment pending\n\nControl group ( n = 5)\nNo more than die inclusion criteria described above.\n\nPatients in both groups should be smokers and drink alcohol regularly to achieve a homogenous collective and in order to avoid overinterpretion of VOCs emitted through smoking/alcohol.""]","[""Exclusion Criteria"",""- Previous malignancies\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, not controlled diabetes)\n- HIV infection\n- Drug addiction\n- Patients under 18 years old\n- Patients over 70 years\n- Karnofsky Index : < 80 %\n- Participation in a similar study""]","[""Detectable tumor-specific signature VOCs at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable tumor-specific signature VOCs after surgery with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Virchow-Klinikum\nMr. Dr. med. Stefan Hartwig \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Campus Virchow-Klinikum"",""Mr. Dr. med. Stefan Hartwig "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +4939450655148\nFax: [---]*\nE-mail: stefan.hartwig at charite.de\nURL: http://www.charite.de"",""Telephone: +4939450655148"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: stefan.hartwig at charite.de"",""E-mail:"",""stefan.hartwig at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00009539,5,5,2017-10-19,"Recruiting complete, follow-up complete",2014-11-19,2015-09-14,20,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""- Ability ( verbal , physically and mentally ) to understand the nature of the study and to participate\n- Willingness to study participation\n- Completed and signed informed consent\n- Age between 18 and 70 years\n- Karnofsky - Index : 80%\n- Smoking ( > 10 pack years , > 15 cigarettes / day )\n- Regular alcohol consumption ( < 50 g / week )\n\nTest group ( n = 15)\nSpecific inclusion criteria\n- Histologically confirmed primary PECA in the region of the oral cavity and oropharynx\n- Surgical treatment pending\n\nControl group ( n = 5)\nNo more than die inclusion criteria described above.\n\nPatients in both groups should be smokers and drink alcohol regularly to achieve a homogenous collective and in order to avoid overinterpretion of VOCs emitted through smoking/alcohol.""]","[""Exclusion Criteria"",""- Previous malignancies\n- Severe internal comorbidities (myocardial infarction, cardiomyopathy, NYHA functional class III / IV, severe COPD, renal failure, not controlled diabetes)\n- HIV infection\n- Drug addiction\n- Patients under 18 years old\n- Patients over 70 years\n- Karnofsky Index : < 80 %\n- Participation in a similar study""]","[""Detectable tumor-specific signature VOCs at diagnosis with the help of gas chromatography and mass spectrometry""]","[""No detectable tumor-specific signature VOCs after surgery with the help of gas chromatography and mass spectrometry""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Charité Campus Berlin Buch\nMr. PD Dr. Robert Preissner \nLindenberger Weg 80\n13125 Berlin\nGermany"",""Charité Campus Berlin Buch"",""Mr. PD Dr. Robert Preissner "",""Lindenberger Weg 80"",""13125 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin\nMs. PD Dr. Saskia Preissner \nAssmannshauser Str. 4-6\n14197 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Ms. PD Dr. Saskia Preissner "",""Assmannshauser Str. 4-6"",""14197 Berlin"",""Germany"",""Telephone: +4930450562675\nFax: [---]*\nE-mail: saskia.preissner at charite.de\nURL: http://www.charite.de"",""Telephone: +4930450562675"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: saskia.preissner at charite.de"",""E-mail:"",""saskia.preissner at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Virchow-Klinikum\nMr. Dr. med. Stefan Hartwig \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Campus Virchow-Klinikum"",""Mr. Dr. med. Stefan Hartwig "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +4939450655148\nFax: [---]*\nE-mail: stefan.hartwig at charite.de\nURL: http://www.charite.de"",""Telephone: +4939450655148"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: stefan.hartwig at charite.de"",""E-mail:"",""stefan.hartwig at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00011212,1,1,2016-10-28,"Recruiting complete, follow-up complete",2015-10-16,2016-06-10,33,Actual,18 Years,60 Years,"Both, male and female","[""Additional Inclusion Criteria"",""Healthy individuals aged between 18 and 60 years who have given their informed consent were admitted.""]","[""Exclusion Criteria"",""Exclusion criteria: skin diseases or skin barrier disorders, metallic implants in the forearms, adverse reactions to cosmetics, allergies and food intolerances, pregnancy and lactation, subjects unable to make decisions for themselves.""]","[""Radical scavenging activity in the skin at baseline and after 14 days, measured with electron paramagnetic resonance spectroscopy""]","[""Carotenoid content of the skin at baseline and after 14 days, measured with resonance Raman spectroscopy""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité-Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie\nMr. Jürgen Lademann \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Klinik für Dermatologie, Venerologie und Allergologie"",""Mr. Jürgen Lademann "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030 450 518100\nFax: [---]*\nE-mail: juergen.lademann at charite.de\nURL: [---]*"",""Telephone: 030 450 518100"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: juergen.lademann at charite.de"",""E-mail:"",""juergen.lademann at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité-Universitätsmedizin BerlinKlinik für Dermatologie, Venerologie und Allergologie\nMs. Inna Megow \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin BerlinKlinik für Dermatologie, Venerologie und Allergologie"",""Ms. Inna Megow "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030 450 518 208\nFax: [---]*\nE-mail: inna.megow at charite.de\nURL: [---]*"",""Telephone: 030 450 518 208"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: inna.megow at charite.de"",""E-mail:"",""inna.megow at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00011273,1,2,2016-11-02,Recruiting planned,2016-11-03,NA,30,Planned,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Both women (after exclusion of a pregnancy) and men older than 18 years are included, with planned manual guided pulmonary vein isolation using cryo-energy.\nThere must be no contraindications for anticoagulation. Admission to study participation is required.""]","[""Exclusion Criteria"",""Catheter ablation within 3 months before the planned pulmonary vein isolation using cryo-energy.\nPneumonia within 3 months prior to ablation.\nPatients with a COPD Gold III-IV or a known change in the bronchial system.\nPatients with known or impaired pulmonary malignancy.\nExisting contraindication to perform bronchoscopy.""]","[""Incidence of Bronchial lesions after Cryoablation.""]","[""Classification of the bronchial lesions by severity.\n\nTemperature profile during cooling and influence on the incidence of bronchial lesions.\n\nThawing behavior of the cryoballon and influence on the incidence of bronchial lesions.\n\nEffect of the temperature profile of the routinely used esophageal temperature probe on the incidence of bronchial lesions.""]","[""Primary Sponsor"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin\nMs. Dr. med. Barbara Bellmann \nHindenburgdamm 30\n12003 Berlin\nGermany"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin"",""Ms. Dr. med. Barbara Bellmann "",""Hindenburgdamm 30"",""12003 Berlin"",""Germany"",""Telephone: 030450513847\nFax: [---]*\nE-mail: barbarabellmann at charite.de\nURL: [---]*"",""Telephone: 030450513847"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: barbarabellmann at charite.de"",""E-mail:"",""barbarabellmann at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin\nMs. Dr. med. Barbara Bellmann \nHindenburgdamm 30\n12003 Berlin\nGermany"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin"",""Ms. Dr. med. Barbara Bellmann "",""Hindenburgdamm 30"",""12003 Berlin"",""Germany"",""Telephone: 030450513847\nFax: [---]*\nE-mail: barbarabellmann at charite.de\nURL: [---]*"",""Telephone: 030450513847"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: barbarabellmann at charite.de"",""E-mail:"",""barbarabellmann at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin\nMs. Dr. med. Barbara Bellmann \nHindenburgdamm 30\n12003 Berlin\nGermany"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin"",""Ms. Dr. med. Barbara Bellmann "",""Hindenburgdamm 30"",""12003 Berlin"",""Germany"",""Telephone: 030450513847\nFax: [---]*\nE-mail: barbarabellmann at charite.de\nURL: [---]*"",""Telephone: 030450513847"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: barbarabellmann at charite.de"",""E-mail:"",""barbarabellmann at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00011273,2,2,2017-12-04,"Recruiting complete, follow-up complete",2016-11-03,2017-05-23,30,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Both women (after exclusion of a pregnancy) and men older than 18 years are included, with planned manual guided pulmonary vein isolation using cryo-energy.\nThere must be no contraindications for anticoagulation. Admission to study participation is required.""]","[""Exclusion Criteria"",""Catheter ablation within 3 months before the planned pulmonary vein isolation using cryo-energy.\nPneumonia within 3 months prior to ablation.\nPatients with a COPD Gold III-IV or a known change in the bronchial system.\nPatients with known or impaired pulmonary malignancy.\nExisting contraindication to perform bronchoscopy.""]","[""Incidence of Bronchial lesions after Cryoablation.""]","[""Classification of the bronchial lesions by severity.\n\nTemperature profile during cooling and influence on the incidence of bronchial lesions.\n\nThawing behavior of the cryoballon and influence on the incidence of bronchial lesions.\n\nEffect of the temperature profile of the routinely used esophageal temperature probe on the incidence of bronchial lesions.""]","[""Primary Sponsor"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin\nMs. Dr. med. Barbara Bellmann \nHindenburgdamm 30\n12003 Berlin\nGermany"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin"",""Ms. Dr. med. Barbara Bellmann "",""Hindenburgdamm 30"",""12003 Berlin"",""Germany"",""Telephone: 030450513847\nFax: [---]*\nE-mail: barbarabellmann at charite.de\nURL: [---]*"",""Telephone: 030450513847"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: barbarabellmann at charite.de"",""E-mail:"",""barbarabellmann at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin\nMs. Dr. med. Barbara Bellmann \nHindenburgdamm 30\n12003 Berlin\nGermany"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin"",""Ms. Dr. med. Barbara Bellmann "",""Hindenburgdamm 30"",""12003 Berlin"",""Germany"",""Telephone: 030450513847\nFax: [---]*\nE-mail: barbarabellmann at charite.de\nURL: [---]*"",""Telephone: 030450513847"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: barbarabellmann at charite.de"",""E-mail:"",""barbarabellmann at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin\nMs. Dr. med. Barbara Bellmann \nHindenburgdamm 30\n12003 Berlin\nGermany"",""Charite BerlinAbteilung für KardiologieCampus Benjamin Franklin"",""Ms. Dr. med. Barbara Bellmann "",""Hindenburgdamm 30"",""12003 Berlin"",""Germany"",""Telephone: 030450513847\nFax: [---]*\nE-mail: barbarabellmann at charite.de\nURL: [---]*"",""Telephone: 030450513847"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: barbarabellmann at charite.de"",""E-mail:"",""barbarabellmann at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012499,1,2,2017-07-14,Recruiting ongoing,2016-01-09,NA,1000,Actual,no minimum age,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Patient referred for gastroscopy for one of the following reasons: dyspepsia, abdominal pain, unexplained anemia, weight loss, diarrhea, gastroesophageal reflux symptoms, dysphagia, suspected gastrointestinal bleeding""]","[""Exclusion Criteria"",""Coagulopaty, known diagnosis of celiac disease and ongoing gluten-free diet.""]","[""Sensitivity, Specificity""]","[""Celiac disease Prevalence""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Med. Klinik für Gastroenterologie, Infektiologie und RheumatologieCharité Campus Benjamin Franklin\nMr. Dr. med. Michael Schumann \nHindenburgdamm 30\n12203 Berlin\nGermany"",""Med. Klinik für Gastroenterologie, Infektiologie und RheumatologieCharité Campus Benjamin Franklin"",""Mr. Dr. med. Michael Schumann "",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: 030/450514536\nFax: [---]*\nE-mail: michael.schumann at charite.de\nURL: http://www.charite.de"",""Telephone: 030/450514536"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: michael.schumann at charite.de"",""E-mail:"",""michael.schumann at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin\nMr. Paul Tangermann \nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Mr. Paul Tangermann "",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: +491723667584\nFax: [---]*\nE-mail: paul.tangermann at charite.de\nURL: http://www.charite.de"",""Telephone: +491723667584"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: paul.tangermann at charite.de"",""E-mail:"",""paul.tangermann at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00012499,2,2,2018-01-15,"Recruiting complete, follow-up complete",2016-01-09,2017-12-29,1000,Actual,no minimum age,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Patient referred for gastroscopy for one of the following reasons: dyspepsia, abdominal pain, unexplained anemia, weight loss, diarrhea, gastroesophageal reflux symptoms, dysphagia, suspected gastrointestinal bleeding""]","[""Exclusion Criteria"",""Coagulopaty, known diagnosis of celiac disease and ongoing gluten-free diet.""]","[""Sensitivity, Specificity""]","[""Celiac disease Prevalence""]","[""Primary Sponsor"",""Charité Campus Benjamin Franklin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Med. Klinik für Gastroenterologie, Infektiologie und RheumatologieCharité Campus Benjamin Franklin\nMr. Dr. med. Michael Schumann \nHindenburgdamm 30\n12203 Berlin\nGermany"",""Med. Klinik für Gastroenterologie, Infektiologie und RheumatologieCharité Campus Benjamin Franklin"",""Mr. Dr. med. Michael Schumann "",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: 030/450514536\nFax: [---]*\nE-mail: michael.schumann at charite.de\nURL: http://www.charite.de"",""Telephone: 030/450514536"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: michael.schumann at charite.de"",""E-mail:"",""michael.schumann at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin\nMr. Paul Tangermann \nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Mr. Paul Tangermann "",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: +491723667584\nFax: [---]*\nE-mail: paul.tangermann at charite.de\nURL: http://www.charite.de"",""Telephone: +491723667584"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: paul.tangermann at charite.de"",""E-mail:"",""paul.tangermann at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00012795,1,3,2017-07-27,"Recruiting complete, follow-up complete",2013-04-02,2014-12-17,30,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""patients with suspicion of Obstructive Sleep Apnea (OSA)""]","[""Exclusion Criteria"",""- drug use and excessive alcohol consumption\n- any medication intake that could influence sleep\n- presence of any sleep disorder other than OSA\n- clinically unstable respiratory or cardiovascular disease\n- prior treatment of OSA""]","[""Degree of agreement between the new sensor (CID-102) with the reference measurement (RIP - Respiratory Inductance Plethysmography) in terms of detection of three different pattern of disturbed breathing (obstructive apnea, central apnea, mixed apnea) explored by analysis of correlation, sensitivity, and specificity.""]","[""Interrater variability of scoring of obstructive apneas, central apneas, and mixed apneas with the new sensor (CID-102) during sleep""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. med. Ingo Fietze \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. med. Ingo Fietze "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49-30-450513122\nFax: [---]*\nE-mail: ingo.fietze at charite.de\nURL: [---]*"",""Telephone: +49-30-450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: ingo.fietze at charite.de"",""E-mail:"",""ingo.fietze at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012795,2,3,2017-08-04,"Recruiting complete, follow-up complete",2013-04-02,2014-12-17,30,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""patients with suspicion of Obstructive Sleep Apnea (OSA)""]","[""Exclusion Criteria"",""- drug use and excessive alcohol consumption\n- any medication intake that could influence sleep\n- presence of any sleep disorder other than OSA\n- clinically unstable respiratory or cardiovascular disease\n- prior treatment of OSA""]","[""Degree of agreement between the new sensor (CID-102) with the reference measurement (RIP - Respiratory Inductance Plethysmography) in terms of detection of three different pattern of disturbed breathing (obstructive apnea, central apnea, mixed apnea) explored by analysis of correlation, sensitivity, and specificity.""]","[""Interrater variability of scoring of obstructive apneas, central apneas, and mixed apneas with the new sensor (CID-102) during sleep""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. med. Ingo Fietze \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. med. Ingo Fietze "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49-30-450513122\nFax: [---]*\nE-mail: ingo.fietze at charite.de\nURL: [---]*"",""Telephone: +49-30-450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: ingo.fietze at charite.de"",""E-mail:"",""ingo.fietze at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012795,3,3,2018-08-31,"Recruiting complete, follow-up complete",2013-04-02,2014-12-17,30,Actual,18 Years,70 Years,"Both, male and female","[""Additional Inclusion Criteria"",""patients with suspicion of Obstructive Sleep Apnea (OSA)""]","[""Exclusion Criteria"",""- drug use and excessive alcohol consumption\n- any medication intake that could influence sleep\n- presence of any sleep disorder other than OSA\n- clinically unstable respiratory or cardiovascular disease\n- prior treatment of OSA""]","[""Degree of agreement between the new sensor (CID-102) with the reference measurement (RIP - Respiratory Inductance Plethysmography) in terms of detection of three different pattern of disturbed breathing (obstructive apnea, central apnea, mixed apnea) explored by analysis of correlation, sensitivity, and specificity.""]","[""Interrater variability of scoring of obstructive apneas, central apneas, and mixed apneas with the new sensor (CID-102) during sleep""]","[""Primary Sponsor"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. Thomas Penzel \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. Thomas Penzel "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +4930450513122\nFax: [---]*\nE-mail: thomas.penzel at charite.de\nURL: [---]*"",""Telephone: +4930450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: thomas.penzel at charite.de"",""E-mail:"",""thomas.penzel at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum\nMr. Prof. Dr. med. Ingo Fietze \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité-Universitätsmedizin Berlin, Interdisziplinäres Schlafmedizinisches Zentrum"",""Mr. Prof. Dr. med. Ingo Fietze "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49-30-450513122\nFax: [---]*\nE-mail: ingo.fietze at charite.de\nURL: [---]*"",""Telephone: +49-30-450513122"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: ingo.fietze at charite.de"",""E-mail:"",""ingo.fietze at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00004911,1,3,2013-04-29,Recruiting ongoing,2013-02-27,NA,90,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Presence of hypertension under drug therapy or ≥ 140/90 mmHg without antihypertensive therapy. Furthermore, walking ability, adequate linguistic knowledge, age>18 years, ability to give informed consent.""]","[""Exclusion Criteria"",""High grade peripheral vascular disease (> stage 1), Aortenvitium (> grade 1), hypertrophic obstructive cardiomyopathy, high grade heart failure (> NYHA II), uncontrolled cardiac arrhythmias, systolic resting blood pressure ≥ 180 mmHg and / or diastolic resting blood pressure ≥ 110mmHg , participation in other clinical trial. For performing the handgrip exercise patients with advanced arthritis in the hands or acute Medianus Kompression Syndrom will be excluded.""]","[""Reduction of systolic and diastolic blood pressure in the clinic and ambulatory 24-hour blood-pressure measurement after the exercise training (12 weeks).""]","[""Changes in endothelial function measured by FMD (flow mediated dilation). Changes of the arterial stiffness by applanation tonometry with the HEM9000-AI unit of the company Omron. Determination of the augmentation index (AI).\nElasticity index of large arteries (systemic arterial compliance), elasticity index of small arteries (arterial compliance by oscillometry), total peripheral resistance and cardiac output by pulse wave analysis using the HDI / Pulse Wave ™.\nBlood sampling for determination of nitrite, nitrate, superoxide dismutase and endothelial progenitor cells (EPC). All these examinations take place before and after the first phase of the study (12 weeks). Patients who take part in the second phase (add-on therapy) will undertake the same examinations once more 24 weeks after recruitment in the trial.""]","[""Primary Sponsor"",""Charité, Universitaetsmedizin Berlin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité, Universitaetsmedizin Berlin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Campus Benjamin Franklin\nMr. Dr. med. Nikolaos Pagonas \nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Mr. Dr. med. Nikolaos Pagonas "",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: 00493084452623\nFax: 00493084454235\nE-mail: nikolaos.pagonas at charite.de\nURL: http://www.charite.de"",""Telephone: 00493084452623"",""Telephone:"",""Fax: 00493084454235"",""Fax:"",""E-mail: nikolaos.pagonas at charite.de"",""E-mail:"",""nikolaos.pagonas at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin\nMr. Dr. med. Nikolaos Pagonas \nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Mr. Dr. med. Nikolaos Pagonas "",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: 03084452623\nFax: 03084454235\nE-mail: nikolaos.pagonas at charite.de\nURL: http://www.charite.de"",""Telephone: 03084452623"",""Telephone:"",""Fax: 03084454235"",""Fax:"",""E-mail: nikolaos.pagonas at charite.de"",""E-mail:"",""nikolaos.pagonas at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00004911,2,3,2014-02-03,Recruiting ongoing,2013-02-27,NA,90,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Presence of hypertension under drug therapy or ≥ 140/90 mmHg without antihypertensive therapy. Furthermore, walking ability, adequate linguistic knowledge, age>18 years, ability to give informed consent.""]","[""Exclusion Criteria"",""High grade peripheral vascular disease (> stage 1), Aortenvitium (> grade 1), hypertrophic obstructive cardiomyopathy, high grade heart failure (> NYHA II), uncontrolled cardiac arrhythmias, systolic resting blood pressure ≥ 180 mmHg and / or diastolic resting blood pressure ≥ 110mmHg , participation in other clinical trial. For performing the handgrip exercise patients with advanced arthritis in the hands or acute Medianus Kompression Syndrom will be excluded.""]","[""Reduction of systolic and diastolic blood pressure in the clinic and ambulatory 24-hour blood-pressure measurement after the exercise training (12 weeks).""]","[""Changes in endothelial function measured by FMD (flow mediated dilation). Changes of the arterial stiffness by applanation tonometry with the HEM9000-AI unit of the company Omron. Determination of the augmentation index (AI).\nElasticity index of large arteries (systemic arterial compliance), elasticity index of small arteries (arterial compliance by oscillometry), total peripheral resistance and cardiac output by pulse wave analysis using the HDI / Pulse Wave ™.\nBlood sampling for determination of nitrite, nitrate, superoxide dismutase and endothelial progenitor cells (EPC). All these examinations take place before and after the first phase of the study (12 weeks). Patients who take part in the second phase (add-on therapy) will undertake the same examinations once more 24 weeks after recruitment in the trial.""]","[""Primary Sponsor"",""Charité, Universitaetsmedizin Berlin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité, Universitaetsmedizin Berlin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Marienhospital Herne, Universitätsklinikum Ruhr Universität Bochum\nMr. Dr. med. Nikolaos Pagonas \nHölkeskampring 40\n44625 Bochum\nGermany"",""Marienhospital Herne, Universitätsklinikum Ruhr Universität Bochum"",""Mr. Dr. med. Nikolaos Pagonas "",""Hölkeskampring 40"",""44625 Bochum"",""Germany"",""Telephone: 004923234995148\nFax: 00492323499302\nE-mail: nikolaos.pagonas at marienhospital-herne.de\nURL: http://www.marien-herne.de"",""Telephone: 004923234995148"",""Telephone:"",""Fax: 00492323499302"",""Fax:"",""E-mail: nikolaos.pagonas at marienhospital-herne.de"",""E-mail:"",""nikolaos.pagonas at marienhospital-herne.de"",""URL: http://www.marien-herne.de"",""URL:"",""http://www.marien-herne.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin\nMr. Stergios Vlatsas \nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Mr. Stergios Vlatsas "",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: 03084452623\nFax: 03084454235\nE-mail: stergios.vlatsas at charite.de\nURL: http://www.charite.de"",""Telephone: 03084452623"",""Telephone:"",""Fax: 03084454235"",""Fax:"",""E-mail: stergios.vlatsas at charite.de"",""E-mail:"",""stergios.vlatsas at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00004911,3,3,2015-10-15,"Recruiting complete, follow-up complete",2013-02-27,2014-11-28,90,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Presence of hypertension under drug therapy or ≥ 140/90 mmHg without antihypertensive therapy. Furthermore, walking ability, adequate linguistic knowledge, age>18 years, ability to give informed consent.""]","[""Exclusion Criteria"",""High grade peripheral vascular disease (> stage 1), Aortenvitium (> grade 1), hypertrophic obstructive cardiomyopathy, high grade heart failure (> NYHA II), uncontrolled cardiac arrhythmias, systolic resting blood pressure ≥ 180 mmHg and / or diastolic resting blood pressure ≥ 110mmHg , participation in other clinical trial. For performing the handgrip exercise patients with advanced arthritis in the hands or acute Medianus Kompression Syndrom will be excluded.""]","[""Reduction of systolic and diastolic blood pressure in the clinic and ambulatory 24-hour blood-pressure measurement after the exercise training (12 weeks).""]","[""Changes in endothelial function measured by FMD (flow mediated dilation). Changes of the arterial stiffness by applanation tonometry with the HEM9000-AI unit of the company Omron. Determination of the augmentation index (AI).\nElasticity index of large arteries (systemic arterial compliance), elasticity index of small arteries (arterial compliance by oscillometry), total peripheral resistance and cardiac output by pulse wave analysis using the HDI / Pulse Wave ™.\nBlood sampling for determination of nitrite, nitrate, superoxide dismutase and endothelial progenitor cells (EPC). All these examinations take place before and after the first phase of the study (12 weeks). Patients who take part in the second phase (add-on therapy) will undertake the same examinations once more 24 weeks after recruitment in the trial.""]","[""Primary Sponsor"",""Charité, Universitaetsmedizin Berlin\nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité, Universitaetsmedizin Berlin"",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Marienhospital Herne, Universitätsklinikum Ruhr Universität Bochum\nMr. Dr. med. Nikolaos Pagonas \nHölkeskampring 40\n44625 Bochum\nGermany"",""Marienhospital Herne, Universitätsklinikum Ruhr Universität Bochum"",""Mr. Dr. med. Nikolaos Pagonas "",""Hölkeskampring 40"",""44625 Bochum"",""Germany"",""Telephone: 004923234995148\nFax: 00492323499302\nE-mail: nikolaos.pagonas at marienhospital-herne.de\nURL: http://www.marien-herne.de"",""Telephone: 004923234995148"",""Telephone:"",""Fax: 00492323499302"",""Fax:"",""E-mail: nikolaos.pagonas at marienhospital-herne.de"",""E-mail:"",""nikolaos.pagonas at marienhospital-herne.de"",""URL: http://www.marien-herne.de"",""URL:"",""http://www.marien-herne.de"",""Contact for Public Queries"",""Charité Campus Benjamin Franklin\nMr. Stergios Vlatsas \nHindenburgdamm 30\n12203 Berlin\nGermany"",""Charité Campus Benjamin Franklin"",""Mr. Stergios Vlatsas "",""Hindenburgdamm 30"",""12203 Berlin"",""Germany"",""Telephone: 03084452623\nFax: 03084454235\nE-mail: stergios.vlatsas at charite.de\nURL: http://www.charite.de"",""Telephone: 03084452623"",""Telephone:"",""Fax: 03084454235"",""Fax:"",""E-mail: stergios.vlatsas at charite.de"",""E-mail:"",""stergios.vlatsas at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00004195,1,13,2012-08-15,Recruiting ongoing,2012-08-15,NA,350,Planned,14 Years,21 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,2,13,2015-04-13,"Recruiting complete, follow-up complete",2012-08-15,2014-06-30,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,3,13,2015-04-22,"Recruiting complete, follow-up complete",2012-08-15,2014-06-30,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,4,13,2015-04-28,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,5,13,2015-05-12,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,6,13,2015-11-16,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,7,13,2017-03-09,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,8,13,2017-10-23,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,9,13,2018-01-31,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,10,13,2018-06-12,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,11,13,2018-10-12,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,12,13,2019-11-08,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004195,13,13,2019-11-08,"Recruiting complete, follow-up complete",2012-08-15,2014-12-11,350,Actual,14 Years,24 Years,"Both, male and female","[""Additional Inclusion Criteria"",""BMI ≥ 30.0 kg/m2, adequate German language skills""]","[""Exclusion Criteria"",""Conditions requiring immediate inpatient care (e.g. severe somatic or psychiatric illness), obvious cognitive deficits""]","[""Composite of:\na) Compliance rate: Number of regular participants at the time of the 6 months follow up.\nb) Changes (randomization-6 months follow up) in the 37 item DISABKIDS questionnaire.""]","[""1. Changes (randomization-6 months follow up) in the 6 subscales of DISABKIDS.\n2. Changes (randomization-6 months follow up) in quality of life (via KIDSCREEN-52).\n3. Changes (randomization-6 months follow up) in self-esteem (Rosenberg’s scale)\n4. Changes (randomization-6 months follow up) in self reported time spent outside the home.\n5. Changes (randomization-6 months follow up) in depression symptoms (BDI-2).\n6. Changes (randomization-6 months follow up) in perceived stress (Fliege scale).\n7. Changes (randomization-6 months follow up) in the self reported attendance of school, apprenticeship, or work.\n8. Changes (randomization-6 months follow up) in self reported physician- / and therapist contacts.\n""]","[""Primary Sponsor"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Collaborator, Other Address"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMr. Professor Dr. med. Thomas Reinehr \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Mr. Professor Dr. med. Thomas Reinehr "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: +49 2363 975 349\nFax: +49 2363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: +49 2363 975 349"",""Telephone:"",""Fax: +49 2363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Collaborator, Other Address"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Susanne Wiegand \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Susanne Wiegand "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: +49 30 450 566 889\nFax: +49 30 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450 566 889"",""Telephone:"",""Fax: +49 30 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Collaborator, Other Address"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMr. Professor Dr. med. Wieland Kiess \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Mr. Professor Dr. med. Wieland Kiess "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: +49 341 9726000\nFax: +49 341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: +49 341 9726000"",""Telephone:"",""Fax: +49 341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Collaborator, Other Address"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMr. Professor Dr. med. Martin Wabitsch \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Mr. Professor Dr. med. Martin Wabitsch "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: martin.wabitsch at unilkinik-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: martin.wabitsch at unilkinik-ulm.de"",""E-mail:"",""martin.wabitsch at unilkinik-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""University of Ulm\nMr. Prof. Dr. med. Reinhard Holl \nAlbert-Einstein-Allee 41\n89081 Ulm\nGermany"",""University of Ulm"",""Mr. Prof. Dr. med. Reinhard Holl "",""Albert-Einstein-Allee 41"",""89081 Ulm"",""Germany"",""Telephone: +49 731 502 5314\nFax: +49 731 502 5309\nE-mail: [---]*\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 502 5314"",""Telephone:"",""Fax: +49 731 502 5309"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de"",""Collaborator, Other Address"",""Zentrum für klinische Studien Essen\nMr. PD Dr. André Scherag \nHufelanstr. 55\n45122 Essen\nGermany"",""Zentrum für klinische Studien Essen"",""Mr. PD Dr. André Scherag "",""Hufelanstr. 55"",""45122 Essen"",""Germany"",""Telephone: +49 201 723 4793\nFax: +49 201 723 5933\nE-mail: andre.scherag at uk-essen.de\nURL: http://www.zkse.de"",""Telephone: +49 201 723 4793"",""Telephone:"",""Fax: +49 201 723 5933"",""Fax:"",""E-mail: andre.scherag at uk-essen.de"",""E-mail:"",""andre.scherag at uk-essen.de"",""URL: http://www.zkse.de"",""URL:"",""http://www.zkse.de"",""Contact for Scientific Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen\nMr. Prof. Dr. med. Johannes Hebebrand \nWickenburgstr. 21\n45147 Essen\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters LVR-Klinikum Essen Kliniken/Institut der Universität Duisburg-Essen"",""Mr. Prof. Dr. med. Johannes Hebebrand "",""Wickenburgstr. 21"",""45147 Essen"",""Germany"",""Telephone: +49 201 8707 466\nFax: +49 201 7227 302\nE-mail: johannes.hebebrand at uni-due.de\nURL: http://www.rk-essen.lvr.de"",""Telephone: +49 201 8707 466"",""Telephone:"",""Fax: +49 201 7227 302"",""Fax:"",""E-mail: johannes.hebebrand at uni-due.de"",""E-mail:"",""johannes.hebebrand at uni-due.de"",""URL: http://www.rk-essen.lvr.de"",""URL:"",""http://www.rk-essen.lvr.de"",""Contact for Public Queries"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke\nMs. Anke Schäfer \nDr. F. Steiner Str. 5\n45711 Datteln\nGermany"",""Vestische Kinder- und Jugendklinik Universität Witten/Herdecke"",""Ms. Anke Schäfer "",""Dr. F. Steiner Str. 5"",""45711 Datteln"",""Germany"",""Telephone: 02363 975 349\nFax: 02363 975 218\nE-mail: A.Schaefer at kinderklinik-datteln.de\nURL: http://www.kinderklinik-datteln.de"",""Telephone: 02363 975 349"",""Telephone:"",""Fax: 02363 975 218"",""Fax:"",""E-mail: A.Schaefer at kinderklinik-datteln.de"",""E-mail:"",""A.Schaefer at kinderklinik-datteln.de"",""URL: http://www.kinderklinik-datteln.de"",""URL:"",""http://www.kinderklinik-datteln.de"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik\nMs. Dr. med. Annika Bickenbach \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Charité Universitätsmedizin Berlin Ambulantes Adipositas Zentrum Interdisziplinäres SPZ der Kinderklinik"",""Ms. Dr. med. Annika Bickenbach "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: 030 450 566 889\nFax: 030 450 566 926\nE-mail: babeluga at charite.de\nURL: http://www.charite.de"",""Telephone: 030 450 566 889"",""Telephone:"",""Fax: 030 450 566 926"",""Fax:"",""E-mail: babeluga at charite.de"",""E-mail:"",""babeluga at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig\nMs. Annett Witzmann \nLiebigstraße 20a\n04103 Leipzig\nGermany"",""Klinik und Poliklinik für Kinder- und Jugendmedizin am Universitätsklinikum Leipzig Universität Leipzig"",""Ms. Annett Witzmann "",""Liebigstraße 20a"",""04103 Leipzig"",""Germany"",""Telephone: 0341 9726000\nFax: 0341 9726009\nE-mail: Annett.Witzmann at medizin.uni-leipzig.de\nURL: http://kik.uniklinikum-leipzig.de"",""Telephone: 0341 9726000"",""Telephone:"",""Fax: 0341 9726009"",""Fax:"",""E-mail: Annett.Witzmann at medizin.uni-leipzig.de"",""E-mail:"",""Annett.Witzmann at medizin.uni-leipzig.de"",""URL: http://kik.uniklinikum-leipzig.de"",""URL:"",""http://kik.uniklinikum-leipzig.de"",""Contact for Public Queries"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm\nMs. Dr. med. Belinda Lennerz \nEythstraße 24\n89075 Ulm\nGermany"",""Klinik für Kinder- und Jugendmedizin, Universität Ulm"",""Ms. Dr. med. Belinda Lennerz "",""Eythstraße 24"",""89075 Ulm"",""Germany"",""Telephone: +49 731 500 57401\nFax: +49 731 500 57413\nE-mail: ja-studie at uni-ulm.de\nURL: http://www.uni-ulm.de"",""Telephone: +49 731 500 57401"",""Telephone:"",""Fax: +49 731 500 57413"",""Fax:"",""E-mail: ja-studie at uni-ulm.de"",""E-mail:"",""ja-studie at uni-ulm.de"",""URL: http://www.uni-ulm.de"",""URL:"",""http://www.uni-ulm.de""]"
DRKS00004649,1,5,2013-01-31,Recruiting ongoing,2013-01-01,NA,240,Actual,18 Years,no maximum age,Female,"[""Additional Inclusion Criteria"",""Mothers with and without adverse childhood experiences and with 5-12 years old children""]","[""Exclusion Criteria"",""Participants with contraindications against MRI will be excluded from the study. Participants with claustrophobia, acute suicidality or drug dependency will be also excluded. In addition, control-dyads must not have any traumatic childhood experiences.""]","[""Mother: Changes in maternal sensitivity from baseline to follow-up I (after intervention) (EA-score). Child: Changes in the child's well-being from baseline to follow-up I (after intervention) (KIDS-SCREEN-score).""]","[""Mother: Changes in maternal sensitivity, Intrusivity and hostility from baseline to follow-up II (6 months after intervention) in EA-scores as well as changes in maternal psychopathology from baseline to follow-up I (after intervention) and II (6 months after intervention) (HAMD, SCL-90-R, BDI-II, IRI, PSI, scores) and in maternal abuse risk (EBSK, score). Child: Changes in the child's responsiveness (EA-scales) and the child's well-being (KIDS-SCREEN score) from baseline to follow-up II (6 months after intervention) as well as changes in the child's behavior from baseline to follow-up I (after intervention) and II (6 months after intervention) (CBCL, TRF, scores).""]","[""Primary Sponsor"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. Sabine Herpertz \nVoßstr. 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. Sabine Herpertz "",""Voßstr. 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Collaborator, Other Address"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum\nMs. Dr. phil. Katja Bödeker \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum"",""Ms. Dr. phil. Katja Bödeker "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: (030) 450566436\nFax: (030) 450566923\nE-mail: Katja.Boedeker at charite.de\nURL: [---]*"",""Telephone: (030) 450566436"",""Telephone:"",""Fax: (030) 450566923"",""Fax:"",""E-mail: Katja.Boedeker at charite.de"",""E-mail:"",""Katja.Boedeker at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. med. Sabine Herpertz \nVoßstraße 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. med. Sabine Herpertz "",""Voßstraße 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Contact for Public Queries"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus\nMr. Prof. Dr. Felix Bermpohl \nGroße Hamburger Str. 5-11\n10115 Berlin\nGermany"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus"",""Mr. Prof. Dr. Felix Bermpohl "",""Große Hamburger Str. 5-11"",""10115 Berlin"",""Germany"",""Telephone: 030-2311-2949\nFax: 030-2311-2929\nE-mail: felix.bermpohl at charite.de\nURL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""Telephone: 030-2311-2949"",""Telephone:"",""Fax: 030-2311-2929"",""Fax:"",""E-mail: felix.bermpohl at charite.de"",""E-mail:"",""felix.bermpohl at charite.de"",""URL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""URL:"",""http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/""]"
DRKS00004649,2,5,2013-08-05,Recruiting ongoing,2013-01-01,NA,240,Actual,18 Years,no maximum age,Female,"[""Additional Inclusion Criteria"",""Mothers with and without adverse childhood experiences and with 5-12 years old children""]","[""Exclusion Criteria"",""Participants with contraindications against MRI will be excluded from the study. Participants with claustrophobia, acute suicidality or drug dependency will be also excluded. In addition, control-dyads must not have any traumatic childhood experiences.""]","[""Mother: Changes in maternal sensitivity from baseline to follow-up I (after intervention) (EA-score). Child: Changes in the child's well-being from baseline to follow-up I (after intervention) (KIDS-SCREEN-score).""]","[""Mother: Changes in maternal sensitivity, Intrusivity and hostility from baseline to follow-up II (6 months after intervention) in EA-scores as well as changes in maternal psychopathology from baseline to follow-up I (after intervention) and II (6 months after intervention) (HAMD, SCL-90-R, BDI-II, IRI, PSI, scores) and in maternal abuse risk (EBSK, score). Child: Changes in the child's responsiveness (EA-scales) and the child's well-being (KIDS-SCREEN score) from baseline to follow-up II (6 months after intervention) as well as changes in the child's behavior from baseline to follow-up I (after intervention) and II (6 months after intervention) (CBCL, TRF, scores).""]","[""Primary Sponsor"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. Sabine Herpertz \nVoßstr. 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. Sabine Herpertz "",""Voßstr. 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Collaborator, Other Address"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum\nMs. Dr. phil. Katja Bödeker \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum"",""Ms. Dr. phil. Katja Bödeker "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: (030) 450566436\nFax: (030) 450566923\nE-mail: Katja.Boedeker at charite.de\nURL: [---]*"",""Telephone: (030) 450566436"",""Telephone:"",""Fax: (030) 450566923"",""Fax:"",""E-mail: Katja.Boedeker at charite.de"",""E-mail:"",""Katja.Boedeker at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. med. Sabine Herpertz \nVoßstraße 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. med. Sabine Herpertz "",""Voßstraße 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Contact for Public Queries"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus\nMr. Prof. Dr. Felix Bermpohl \nGroße Hamburger Str. 5-11\n10115 Berlin\nGermany"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus"",""Mr. Prof. Dr. Felix Bermpohl "",""Große Hamburger Str. 5-11"",""10115 Berlin"",""Germany"",""Telephone: 030-2311-2949\nFax: 030-2311-2929\nE-mail: felix.bermpohl at charite.de\nURL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""Telephone: 030-2311-2949"",""Telephone:"",""Fax: 030-2311-2929"",""Fax:"",""E-mail: felix.bermpohl at charite.de"",""E-mail:"",""felix.bermpohl at charite.de"",""URL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""URL:"",""http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/""]"
DRKS00004649,3,5,2014-02-10,Recruiting ongoing,2013-01-01,NA,240,Actual,18 Years,no maximum age,Female,"[""Additional Inclusion Criteria"",""Mothers with and without adverse childhood experiences and with 5-12 years old children""]","[""Exclusion Criteria"",""Participants with contraindications against MRI will be excluded from the study. Participants with claustrophobia, acute suicidality or drug dependency will be also excluded. In addition, control-dyads must not have any traumatic childhood experiences.""]","[""Mother: Changes in maternal sensitivity from baseline to follow-up I (after intervention) (EA-score). Child: Changes in the child's well-being from baseline to follow-up I (after intervention) (KIDS-SCREEN-score).""]","[""Mother: Changes in maternal sensitivity, Intrusivity and hostility from baseline to follow-up II (6 months after intervention) in EA-scores as well as changes in maternal psychopathology from baseline to follow-up I (after intervention) and II (6 months after intervention) (HAMD, SCL-90-R, BDI-II, IRI, PSI, scores) and in maternal abuse risk (EBSK, score). Child: Changes in the child's responsiveness (EA-scales) and the child's well-being (KIDS-SCREEN score) from baseline to follow-up II (6 months after intervention) as well as changes in the child's behavior from baseline to follow-up I (after intervention) and II (6 months after intervention) (CBCL, TRF, scores).""]","[""Primary Sponsor"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. Sabine Herpertz \nVoßstr. 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. Sabine Herpertz "",""Voßstr. 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Collaborator, Other Address"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum\nMs. Dr. phil. Katja Bödeker \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum"",""Ms. Dr. phil. Katja Bödeker "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: (030) 450566436\nFax: (030) 450566923\nE-mail: Katja.Boedeker at charite.de\nURL: [---]*"",""Telephone: (030) 450566436"",""Telephone:"",""Fax: (030) 450566923"",""Fax:"",""E-mail: Katja.Boedeker at charite.de"",""E-mail:"",""Katja.Boedeker at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. med. Sabine Herpertz \nVoßstraße 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. med. Sabine Herpertz "",""Voßstraße 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Contact for Public Queries"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus\nMr. Prof. Dr. Felix Bermpohl \nGroße Hamburger Str. 5-11\n10115 Berlin\nGermany"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus"",""Mr. Prof. Dr. Felix Bermpohl "",""Große Hamburger Str. 5-11"",""10115 Berlin"",""Germany"",""Telephone: 030-2311-2949\nFax: 030-2311-2929\nE-mail: felix.bermpohl at charite.de\nURL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""Telephone: 030-2311-2949"",""Telephone:"",""Fax: 030-2311-2929"",""Fax:"",""E-mail: felix.bermpohl at charite.de"",""E-mail:"",""felix.bermpohl at charite.de"",""URL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""URL:"",""http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/""]"
DRKS00004649,4,5,2016-07-07,"Recruiting complete, follow-up complete",2013-01-01,2016-05-31,240,Actual,18 Years,no maximum age,Female,"[""Additional Inclusion Criteria"",""Mothers with and without adverse childhood experiences and with 5-12 years old children""]","[""Exclusion Criteria"",""Participants with contraindications against MRI will be excluded from the study. Participants with claustrophobia, acute suicidality or drug dependency will be also excluded. In addition, control-dyads must not have any traumatic childhood experiences.""]","[""Mother: Changes in maternal sensitivity from baseline to follow-up I (after intervention) (EA-score). Child: Changes in the child's well-being from baseline to follow-up I (after intervention) (KIDS-SCREEN-score).""]","[""Mother: Changes in maternal sensitivity, Intrusivity and hostility from baseline to follow-up II (6 months after intervention) in EA-scores as well as changes in maternal psychopathology from baseline to follow-up I (after intervention) and II (6 months after intervention) (HAMD, SCL-90-R, BDI-II, IRI, PSI, scores) and in maternal abuse risk (EBSK, score). Child: Changes in the child's responsiveness (EA-scales) and the child's well-being (KIDS-SCREEN score) from baseline to follow-up II (6 months after intervention) as well as changes in the child's behavior from baseline to follow-up I (after intervention) and II (6 months after intervention) (CBCL, TRF, scores).""]","[""Primary Sponsor"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. Sabine Herpertz \nVoßstr. 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. Sabine Herpertz "",""Voßstr. 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Collaborator, Other Address"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum\nMs. Dr. phil. Katja Bödeker \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum"",""Ms. Dr. phil. Katja Bödeker "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: (030) 450566436\nFax: (030) 450566923\nE-mail: Katja.Boedeker at charite.de\nURL: [---]*"",""Telephone: (030) 450566436"",""Telephone:"",""Fax: (030) 450566923"",""Fax:"",""E-mail: Katja.Boedeker at charite.de"",""E-mail:"",""Katja.Boedeker at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. med. Sabine Herpertz \nVoßstraße 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. med. Sabine Herpertz "",""Voßstraße 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Contact for Public Queries"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus\nMr. Prof. Dr. Felix Bermpohl \nGroße Hamburger Str. 5-11\n10115 Berlin\nGermany"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus"",""Mr. Prof. Dr. Felix Bermpohl "",""Große Hamburger Str. 5-11"",""10115 Berlin"",""Germany"",""Telephone: 030-2311-2949\nFax: 030-2311-2929\nE-mail: felix.bermpohl at charite.de\nURL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""Telephone: 030-2311-2949"",""Telephone:"",""Fax: 030-2311-2929"",""Fax:"",""E-mail: felix.bermpohl at charite.de"",""E-mail:"",""felix.bermpohl at charite.de"",""URL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""URL:"",""http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/""]"
DRKS00004649,5,5,2017-01-09,"Recruiting complete, follow-up complete",2013-01-01,2016-05-31,240,Actual,18 Years,no maximum age,Female,"[""Additional Inclusion Criteria"",""Mothers with and without adverse childhood experiences and with 5-12 years old children""]","[""Exclusion Criteria"",""Participants with contraindications against MRI will be excluded from the study. Participants with claustrophobia, acute suicidality or drug dependency will be also excluded. In addition, control-dyads must not have any traumatic childhood experiences.""]","[""Mother: Changes in maternal sensitivity from baseline to follow-up I (after intervention) (EA-score). Child: Changes in the child's well-being from baseline to follow-up I (after intervention) (KIDS-SCREEN-score).""]","[""Mother: Changes in maternal sensitivity, Intrusivity and hostility from baseline to follow-up II (6 months after intervention) in EA-scores as well as changes in maternal psychopathology from baseline to follow-up I (after intervention) and II (6 months after intervention) (HAMD, SCL-90-R, BDI-II, IRI, PSI, scores) and in maternal abuse risk (EBSK, score). Child: Changes in the child's responsiveness (EA-scales) and the child's well-being (KIDS-SCREEN score) from baseline to follow-up II (6 months after intervention) as well as changes in the child's behavior from baseline to follow-up I (after intervention) and II (6 months after intervention) (CBCL, TRF, scores).""]","[""Primary Sponsor"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. Sabine Herpertz \nVoßstr. 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. Sabine Herpertz "",""Voßstr. 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Collaborator, Other Address"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum\nMs. Dr. phil. Katja Bödeker \nAugustenburger Platz 1\n13353 Berlin\nGermany"",""Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters Charité Campus Virchow Klinikum"",""Ms. Dr. phil. Katja Bödeker "",""Augustenburger Platz 1"",""13353 Berlin"",""Germany"",""Telephone: (030) 450566436\nFax: (030) 450566923\nE-mail: Katja.Boedeker at charite.de\nURL: [---]*"",""Telephone: (030) 450566436"",""Telephone:"",""Fax: (030) 450566923"",""Fax:"",""E-mail: Katja.Boedeker at charite.de"",""E-mail:"",""Katja.Boedeker at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg\nMs. Prof. Dr. med. Sabine Herpertz \nVoßstraße 4\n69115 Heidelberg\nGermany"",""Klinik für Allgemeine Psychiatrie Universitätsklinikum Heidelberg"",""Ms. Prof. Dr. med. Sabine Herpertz "",""Voßstraße 4"",""69115 Heidelberg"",""Germany"",""Telephone: 06221-5622751\nFax: 06221-565998\nE-mail: sabine.herpertz at med.uni-heidelberg.de\nURL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Telephone: 06221-5622751"",""Telephone:"",""Fax: 06221-565998"",""Fax:"",""E-mail: sabine.herpertz at med.uni-heidelberg.de"",""E-mail:"",""sabine.herpertz at med.uni-heidelberg.de"",""URL: http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""URL:"",""http://www.klinikum.uni-heidelberg.de/Klinik-fuer-Allgemeine-Psychiatrie.1798.0.html"",""Contact for Public Queries"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus\nMr. Prof. Dr. Felix Bermpohl \nGroße Hamburger Str. 5-11\n10115 Berlin\nGermany"",""Psychiatrische Universitätsklinik der Charité im St. Hedwig-Krankenhaus"",""Mr. Prof. Dr. Felix Bermpohl "",""Große Hamburger Str. 5-11"",""10115 Berlin"",""Germany"",""Telephone: 030-2311-2949\nFax: 030-2311-2929\nE-mail: felix.bermpohl at charite.de\nURL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""Telephone: 030-2311-2949"",""Telephone:"",""Fax: 030-2311-2929"",""Fax:"",""E-mail: felix.bermpohl at charite.de"",""E-mail:"",""felix.bermpohl at charite.de"",""URL: http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/"",""URL:"",""http://psy-ccm.charite.de/forschung/affektive_erkrankungen/ag_affektive_stoerungen/""]"
DRKS00004858,1,5,2014-03-26,Recruiting planned,2014-03-31,NA,12,Planned,18 Years,75 Years,"Both, male and female","[""Additional Inclusion Criteria"",""1. Patients with diagnosis of SLE made and documented by the investigator according to the revised ACR criteria fulfilling ≥ 4 criteria with at least one autoantibody level abnormal (ANA, anti-dsDNA-abs, anti-Sm-abs, anti-Phospholipid-abs).\n2. Active SLE patients with a SELENA-SLEDAI ≥ 6 despite previous treatment with at least two different standard immunosuppressive or immunomodulatory therapies.\n3. An EC approved written informed consent form signed and dated by the patient must be obtained prior to the performance of any protocol procedures and prior to the administration of the study medication (according to AMG §40 (1) 3b).\n4. Stable dosage of standard immunosuppressive or immunomodulatory treatments for at least 4 weeks prior to the first administration of the study medication.\n5. Daily dose of glucocorticosteroids must be ≤ 30mg prednisolone (or equivalent) at the day of baseline visit (Visit 2).\n6. Age of patients >18 years and ≤ 75 years.\n7. Willingness to perform blood analyses and to discontinue therapies which potentially interfere with the study medication.\n8. Female patients of childbearing potential must have a negative serological pregnancy test at the screening visit (Visit 1).\n9. Female patients of childbearing potential must use at least two reliable methods of birth control (1 of which is a barrier method) during study participation and up to 3 months after completion of the last (4th) treatment cycle.\n10. Male patients must agree to use a contraceptive barrier method (eg, condom) with adjunct spermicide during sexual intercourse from the time of the administration of the study medication until at least 3 month after completion of the last (4th) treatment cycle.\n""]","[""Exclusion Criteria"",""1. Hypersensibility to Aldesleukin or its excipients.\n2. Patients with a reduced general condition of 2 or more according to the ECOG (Eastern Cooperative Oncology Group) Performance Status.\n3. Severe impairment of vital organ or life-threatening disease.\n4. Thrombocytopenia with platelet count of <100.000/µl.\n5. Leukocytopenia with WBC of <3.000/µl or neutropenia with a neutrophil count of <1.500/µl.\n6. Anemia with hemoglobin of <9.0 g/dl.\n7. History of thrombotic microangiopathy (TTP).\n8. History of thrombosis or thrombotic event (including venous thrombosis, pulmonary embolism, cortical sinus thrombosis, stroke, or arterial embolism causing digital gangrene or tissue necrosis) within the last 6 month prior to the screening visit (Visit 1).\n9. Infection requiring antibiotic therapy or infection requiring hospitalisation within the last 4 weeks prior to the baseline visit (Visit 2).\n10. Long-term chronically active infectious disease, HIV infection (positive serum antibodies against HIV1/2), active or chronic hepatitis B infection (positive for HBs-Ag in serum), active or chronic hepatitis C infection (positive for serum antibodies against HCV), active tuberculosis.\n11. Pleuritis with pleural effusion of clinical relevance (≥ grade 2 according to the CTCAE v4.03).\n12. Pericarditis with pericardial effusion of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n13. Chronic or acute renal impairment with an eGFR of < 30 ml/min/1.73 m2 (calculated GFR using the MDRD formula with modification for race) or oliguria.\n14. Severe impairment of liver function with elevated plasma levels of bilirubin of ≥ 2 mg/dl or an INR of ≥ 1.7.\n15. Patients with diagnosis of type-1 diabetes mellitus or of Crohn´s Disease.\n16. Patients with inadequately controlled type-2 diabetes mellitus (HbA1c >9%) or patients with type-2 diabetes mellitus and history of recurrent hyperglycemia or hypoglycemia of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n17. Patients who received allogeneic solid organ transplants, except patients who underwent an autologous or allogeneic hematopoetic stem-cell transplantation (HSCT) more than two years prior to the screening visit (Visit 1) and who did not develop graft-versus-host disease (GvHD).\n18. Patients with diagnosis of malignant neoplasm or treatment for malignant neoplasm within the last 5 years prior to the screening visit (Visit 1), except adequately treated basal cell carcinoma or squamous cell carcinoma of the skin and carcinoma in situ of the uterine cervix.\n19. Patients with severe impairment of pulmonary function: severe restrictive lung disease with FVC of <50% of predicted value or obstructive lung disease with FEV1 of <50% of predicted value or O2-saturation of <90% determined by a pulse oxymeter under room air and in resting position.\n20. Severe cardiomyopathy or chronic heart failure with an ejection fraction of <30% or of ≥ grade 3 according to the CTCAE v4.03; instable angina pectoris; coronary heart disease with previous stent implantation within the last 3 month prior to the screening visit (Visit 1) or with three-vessel involvement; cardiac intervention or myocardial infarction within the last 12 month prior to the screening visit (Visit1); history of cardiac arrest.\n21. Cardiac arrhythmias of clinical relevance or requiring permanent treatment (≥ grade 2 according to the CTCAE v4.03); persistent or permanent atrial fibrillation; disturbance of transmission of impulses of clinical relevance (AV-Block >1°).\n22. Valvular heart disease of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n23. Patients with inadequately controlled permanently abnormal heart rate with <45 or >120 beats per minute in resting position.\n24. Patients with inadequately controlled permanent hypotension with systolic blood pressure <100 mmHG or diastolic blood pressure <50 mmHG in resting position.\n25. Patients with inadequately controlled permanent hypertension with systolic blood pressure >160 mmHG or diastolic blood pressure >100 mmHG in resting position.\n26. History of orthostatic dysregulation, fainting, or blackouts within the last 3 month prior to the screening visit (Visit 1).\n27. History of chronic organic psychosis or endogenous psychosis (schizophrenia, mania, bipolar disorder), except mild and transient forms of depression.\n28. History of seizures within the last 6 month prior to the screening visit (Visit 1).\n29. Treatment with Rituximab or any B cell depleting therapy within the last 6 months prior to the screening visit (Visit 1).\n30. Treatment with calcineurin-inhibitors (ciclosporin A, sirolimus, tacrolimus), cyclophosphamide, methotrexate (MTX) or Belimumab within the last 4 weeks prior to the baseline visit (Visit 2).\n31. Treatment with antiproliferative, cytostatic or cytotoxic agents within the last 4 weeks prior to the baseline visit (Visit 2) with the exception of permitted concomitant SLE-related medications.\n32. Treatment with alpha and beta-interferons within the last 4 weeks prior to the baseline visit (Visit 2).\n33. Experimental therapy or participation in another clinical study with investigational medicinal products within the last three month prior to the baseline visit (Visit 2).\n34. Necessity for application of radiographic iodinated contrast media during and 2 weeks after the completion of the last (4th) treatment cycle.\n35. Live vaccination within the last 4 weeks prior to the baseline visit (Visit 2), or plan to receive a live vaccine during study participation.\n36. Major surgery within the last 4 weeks prior to the screening visit (Visit 1) or plan to have elective major surgery during study participation.\n37. Pregnancy and lactating women.\n38. Lack of ability or willingness to practice reliable methods of contraception during the study (female and male participants).\n39. Abuse of alcohol or drugs.\n40. Lack of willingness for storage and transmission of pseudonymized medical data obtained during the clinical study\n41. Minors and subjects who are incapable to provide informed consent or who are considered to be incapable of adhering to the protocol and visit schedule and to be unable to comply with all study requirements according to the judgment of the investigator (according to AMG § 42(2) and (3)).\n42. Subjects kept in detention due to judicial or official order (according to AMG § 40 (1) 4).\n""]","[""The primary endpoint is defined by the increase in the percentage of\nCD25++ cells among CD3+CD4+Foxp3+CD127lo Treg cells by at least\n100% (2-fold) at week 9 (Visit 9; after the 4th treatment cycle)\ncompared to baseline at week 1 (Visit 2; before the 1st treatment cycle).\n\nSafety and tolerability will be evaluated descriptively by assessment of\nthe incidence, frequency, duration, severity and causal relationship to\nthe study medication of any adverse event (clinical and laboratory\ntestings) at every scheduled visit after the screening visit and at every\nunscheduled visit""]","[""• Changes in serum antibody titers for anti-dsDNA-Abs determined by ELISA and by the Crithidia luciliae IFT, serum levels of the complement factors C3 and C4 and serum levels of circulating immune complexes at week 9 (Visit 9) compared to baseline at week 1 (Visit 2)\n• Changes in serum antibody titers for ANA, ENA, anti-SmD1-Abs and other individually relevant serological markers, which were present at baseline or at previous examinations, at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in the disease activity scores SELENA-SLEDAI and BILAG 2004, and changes in PGA and VAS at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in health related Quality of Life (SF36®) one day after the 4th therapeutic cycle (Visit 9; week 9) compared to baseline values (Visit 2; week 1).\n• Changes in organ specific parameters based on individual SLE manifestations either at week 9 (Visit 9) and/or during the follow-up period (weeks 12-18) compared to values obtained at the baseline visit (Visit 2; week 1) or during the screening period.\n• Changes in SLE-associated organ damage by the SLICC/ACR Damage Index one day after the 4th cycle (visit 9; week 9) and at the termination visit (Visit 11; week 18) compared to values at screening visit (Visit 1).\n• Assessment of the durability of clinical and serological responses in subjects who responded to the therapy by comparing values at the follow-up and termination visits (Visits 10 and 11; week 12 and 18) to values from week 9 (Visit 9) and to baseline values (Visit 2; week 1).\n• Assessment of incidence, frequency and severity of SLE flares throughout the whole study.\n""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie\nMs. Prof. Dr. med. Gabriela Riemekasten \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"",""Ms. Prof. Dr. med. Gabriela Riemekasten "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49 30 450613017\nFax: +49 30 450513928\nE-mail: gabriela.riemekasten at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450613017"",""Telephone:"",""Fax: +49 30 450513928"",""Fax:"",""E-mail: gabriela.riemekasten at charite.de"",""E-mail:"",""gabriela.riemekasten at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie\nMr. Dr. med. Jens Humrich \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"",""Mr. Dr. med. Jens Humrich "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49 30 450613413\nFax: +49 30 450513928\nE-mail: jens.humrich at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450613413"",""Telephone:"",""Fax: +49 30 450513928"",""Fax:"",""E-mail: jens.humrich at charite.de"",""E-mail:"",""jens.humrich at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00004858,2,5,2014-04-08,Recruiting ongoing,2014-03-31,NA,12,Actual,18 Years,75 Years,"Both, male and female","[""Additional Inclusion Criteria"",""1. Patients with diagnosis of SLE made and documented by the investigator according to the revised ACR criteria fulfilling ≥ 4 criteria with at least one autoantibody level abnormal (ANA, anti-dsDNA-abs, anti-Sm-abs, anti-Phospholipid-abs).\n2. Active SLE patients with a SELENA-SLEDAI ≥ 6 despite previous treatment with at least two different standard immunosuppressive or immunomodulatory therapies.\n3. An EC approved written informed consent form signed and dated by the patient must be obtained prior to the performance of any protocol procedures and prior to the administration of the study medication (according to AMG §40 (1) 3b).\n4. Stable dosage of standard immunosuppressive or immunomodulatory treatments for at least 4 weeks prior to the first administration of the study medication.\n5. Daily dose of glucocorticosteroids must be ≤ 30mg prednisolone (or equivalent) at the day of baseline visit (Visit 2).\n6. Age of patients >18 years and ≤ 75 years.\n7. Willingness to perform blood analyses and to discontinue therapies which potentially interfere with the study medication.\n8. Female patients of childbearing potential must have a negative serological pregnancy test at the screening visit (Visit 1).\n9. Female patients of childbearing potential must use at least two reliable methods of birth control (1 of which is a barrier method) during study participation and up to 3 months after completion of the last (4th) treatment cycle.\n10. Male patients must agree to use a contraceptive barrier method (eg, condom) with adjunct spermicide during sexual intercourse from the time of the administration of the study medication until at least 3 month after completion of the last (4th) treatment cycle.\n""]","[""Exclusion Criteria"",""1. Hypersensibility to Aldesleukin or its excipients.\n2. Patients with a reduced general condition of 2 or more according to the ECOG (Eastern Cooperative Oncology Group) Performance Status.\n3. Severe impairment of vital organ or life-threatening disease.\n4. Thrombocytopenia with platelet count of <100.000/µl.\n5. Leukocytopenia with WBC of <3.000/µl or neutropenia with a neutrophil count of <1.500/µl.\n6. Anemia with hemoglobin of <9.0 g/dl.\n7. History of thrombotic microangiopathy (TTP).\n8. History of thrombosis or thrombotic event (including venous thrombosis, pulmonary embolism, cortical sinus thrombosis, stroke, or arterial embolism causing digital gangrene or tissue necrosis) within the last 6 month prior to the screening visit (Visit 1).\n9. Infection requiring antibiotic therapy or infection requiring hospitalisation within the last 4 weeks prior to the baseline visit (Visit 2).\n10. Long-term chronically active infectious disease, HIV infection (positive serum antibodies against HIV1/2), active or chronic hepatitis B infection (positive for HBs-Ag in serum), active or chronic hepatitis C infection (positive for serum antibodies against HCV), active tuberculosis.\n11. Pleuritis with pleural effusion of clinical relevance (≥ grade 2 according to the CTCAE v4.03).\n12. Pericarditis with pericardial effusion of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n13. Chronic or acute renal impairment with an eGFR of < 30 ml/min/1.73 m2 (calculated GFR using the MDRD formula with modification for race) or oliguria.\n14. Severe impairment of liver function with elevated plasma levels of bilirubin of ≥ 2 mg/dl or an INR of ≥ 1.7.\n15. Patients with diagnosis of type-1 diabetes mellitus or of Crohn´s Disease.\n16. Patients with inadequately controlled type-2 diabetes mellitus (HbA1c >9%) or patients with type-2 diabetes mellitus and history of recurrent hyperglycemia or hypoglycemia of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n17. Patients who received allogeneic solid organ transplants, except patients who underwent an autologous or allogeneic hematopoetic stem-cell transplantation (HSCT) more than two years prior to the screening visit (Visit 1) and who did not develop graft-versus-host disease (GvHD).\n18. Patients with diagnosis of malignant neoplasm or treatment for malignant neoplasm within the last 5 years prior to the screening visit (Visit 1), except adequately treated basal cell carcinoma or squamous cell carcinoma of the skin and carcinoma in situ of the uterine cervix.\n19. Patients with severe impairment of pulmonary function: severe restrictive lung disease with FVC of <50% of predicted value or obstructive lung disease with FEV1 of <50% of predicted value or O2-saturation of <90% determined by a pulse oxymeter under room air and in resting position.\n20. Severe cardiomyopathy or chronic heart failure with an ejection fraction of <30% or of ≥ grade 3 according to the CTCAE v4.03; instable angina pectoris; coronary heart disease with previous stent implantation within the last 3 month prior to the screening visit (Visit 1) or with three-vessel involvement; cardiac intervention or myocardial infarction within the last 12 month prior to the screening visit (Visit1); history of cardiac arrest.\n21. Cardiac arrhythmias of clinical relevance or requiring permanent treatment (≥ grade 2 according to the CTCAE v4.03); persistent or permanent atrial fibrillation; disturbance of transmission of impulses of clinical relevance (AV-Block >1°).\n22. Valvular heart disease of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n23. Patients with inadequately controlled permanently abnormal heart rate with <45 or >120 beats per minute in resting position.\n24. Patients with inadequately controlled permanent hypotension with systolic blood pressure <100 mmHG or diastolic blood pressure <50 mmHG in resting position.\n25. Patients with inadequately controlled permanent hypertension with systolic blood pressure >160 mmHG or diastolic blood pressure >100 mmHG in resting position.\n26. History of orthostatic dysregulation, fainting, or blackouts within the last 3 month prior to the screening visit (Visit 1).\n27. History of chronic organic psychosis or endogenous psychosis (schizophrenia, mania, bipolar disorder), except mild and transient forms of depression.\n28. History of seizures within the last 6 month prior to the screening visit (Visit 1).\n29. Treatment with Rituximab or any B cell depleting therapy within the last 6 months prior to the screening visit (Visit 1).\n30. Treatment with calcineurin-inhibitors (ciclosporin A, sirolimus, tacrolimus), cyclophosphamide, methotrexate (MTX) or Belimumab within the last 4 weeks prior to the baseline visit (Visit 2).\n31. Treatment with antiproliferative, cytostatic or cytotoxic agents within the last 4 weeks prior to the baseline visit (Visit 2) with the exception of permitted concomitant SLE-related medications.\n32. Treatment with alpha and beta-interferons within the last 4 weeks prior to the baseline visit (Visit 2).\n33. Experimental therapy or participation in another clinical study with investigational medicinal products within the last three month prior to the baseline visit (Visit 2).\n34. Necessity for application of radiographic iodinated contrast media during and 2 weeks after the completion of the last (4th) treatment cycle.\n35. Live vaccination within the last 4 weeks prior to the baseline visit (Visit 2), or plan to receive a live vaccine during study participation.\n36. Major surgery within the last 4 weeks prior to the screening visit (Visit 1) or plan to have elective major surgery during study participation.\n37. Pregnancy and lactating women.\n38. Lack of ability or willingness to practice reliable methods of contraception during the study (female and male participants).\n39. Abuse of alcohol or drugs.\n40. Lack of willingness for storage and transmission of pseudonymized medical data obtained during the clinical study\n41. Minors and subjects who are incapable to provide informed consent or who are considered to be incapable of adhering to the protocol and visit schedule and to be unable to comply with all study requirements according to the judgment of the investigator (according to AMG § 42(2) and (3)).\n42. Subjects kept in detention due to judicial or official order (according to AMG § 40 (1) 4).\n""]","[""The primary endpoint is defined by the increase in the percentage of\nCD25++ cells among CD3+CD4+Foxp3+CD127lo Treg cells by at least\n100% (2-fold) at week 9 (Visit 9; after the 4th treatment cycle)\ncompared to baseline at week 1 (Visit 2; before the 1st treatment cycle).\n\nSafety and tolerability will be evaluated descriptively by assessment of\nthe incidence, frequency, duration, severity and causal relationship to\nthe study medication of any adverse event (clinical and laboratory\ntestings) at every scheduled visit after the screening visit and at every\nunscheduled visit""]","[""• Changes in serum antibody titers for anti-dsDNA-Abs determined by ELISA and by the Crithidia luciliae IFT, serum levels of the complement factors C3 and C4 and serum levels of circulating immune complexes at week 9 (Visit 9) compared to baseline at week 1 (Visit 2)\n• Changes in serum antibody titers for ANA, ENA, anti-SmD1-Abs and other individually relevant serological markers, which were present at baseline or at previous examinations, at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in the disease activity scores SELENA-SLEDAI and BILAG 2004, and changes in PGA and VAS at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in health related Quality of Life (SF36®) one day after the 4th therapeutic cycle (Visit 9; week 9) compared to baseline values (Visit 2; week 1).\n• Changes in organ specific parameters based on individual SLE manifestations either at week 9 (Visit 9) and/or during the follow-up period (weeks 12-18) compared to values obtained at the baseline visit (Visit 2; week 1) or during the screening period.\n• Changes in SLE-associated organ damage by the SLICC/ACR Damage Index one day after the 4th cycle (visit 9; week 9) and at the termination visit (Visit 11; week 18) compared to values at screening visit (Visit 1).\n• Assessment of the durability of clinical and serological responses in subjects who responded to the therapy by comparing values at the follow-up and termination visits (Visits 10 and 11; week 12 and 18) to values from week 9 (Visit 9) and to baseline values (Visit 2; week 1).\n• Assessment of incidence, frequency and severity of SLE flares throughout the whole study.\n""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie\nMs. Prof. Dr. med. Gabriela Riemekasten \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"",""Ms. Prof. Dr. med. Gabriela Riemekasten "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49 30 450613017\nFax: +49 30 450513928\nE-mail: gabriela.riemekasten at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450613017"",""Telephone:"",""Fax: +49 30 450513928"",""Fax:"",""E-mail: gabriela.riemekasten at charite.de"",""E-mail:"",""gabriela.riemekasten at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie\nMr. Dr. med. Jens Humrich \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"",""Mr. Dr. med. Jens Humrich "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49 30 450613413\nFax: +49 30 450513928\nE-mail: jens.humrich at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450613413"",""Telephone:"",""Fax: +49 30 450513928"",""Fax:"",""E-mail: jens.humrich at charite.de"",""E-mail:"",""jens.humrich at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00004858,3,5,2015-04-14,Recruiting ongoing,2014-03-31,NA,12,Actual,18 Years,75 Years,"Both, male and female","[""Additional Inclusion Criteria"",""1. Patients with diagnosis of SLE made and documented by the investigator according to the revised ACR criteria fulfilling ≥ 4 criteria with at least one autoantibody level abnormal (ANA, anti-dsDNA-abs, anti-Sm-abs, anti-Phospholipid-abs).\n2. Active SLE patients with a SELENA-SLEDAI ≥ 6 despite previous treatment with at least two different standard immunosuppressive or immunomodulatory therapies.\n3. An EC approved written informed consent form signed and dated by the patient must be obtained prior to the performance of any protocol procedures and prior to the administration of the study medication (according to AMG §40 (1) 3b).\n4. Stable dosage of standard immunosuppressive or immunomodulatory treatments for at least 4 weeks prior to the first administration of the study medication.\n5. Daily dose of glucocorticosteroids must be ≤ 30mg prednisolone (or equivalent) at the day of baseline visit (Visit 2).\n6. Age of patients >18 years and ≤ 75 years.\n7. Willingness to perform blood analyses and to discontinue therapies which potentially interfere with the study medication.\n8. Female patients of childbearing potential must have a negative serological pregnancy test at the screening visit (Visit 1).\n9. Female patients of childbearing potential must use at least two reliable methods of birth control (1 of which is a barrier method) during study participation and up to 3 months after completion of the last (4th) treatment cycle.\n10. Male patients must agree to use a contraceptive barrier method (eg, condom) with adjunct spermicide during sexual intercourse from the time of the administration of the study medication until at least 3 month after completion of the last (4th) treatment cycle.\n""]","[""Exclusion Criteria"",""1. Hypersensibility to Aldesleukin or its excipients.\n2. Patients with a reduced general condition of 2 or more according to the ECOG (Eastern Cooperative Oncology Group) Performance Status.\n3. Severe impairment of vital organ or life-threatening disease.\n4. Thrombocytopenia with platelet count of <100.000/µl.\n5. Leukocytopenia with WBC of <3.000/µl or neutropenia with a neutrophil count of <1.500/µl.\n6. Anemia with hemoglobin of <9.0 g/dl.\n7. History of thrombotic microangiopathy (TTP).\n8. History of thrombosis or thrombotic event (including venous thrombosis, pulmonary embolism, cortical sinus thrombosis, stroke, or arterial embolism causing digital gangrene or tissue necrosis) within the last 6 month prior to the screening visit (Visit 1).\n9. Infection requiring antibiotic therapy or infection requiring hospitalisation within the last 4 weeks prior to the baseline visit (Visit 2).\n10. Long-term chronically active infectious disease, HIV infection (positive serum antibodies against HIV1/2), active or chronic hepatitis B infection (positive for HBs-Ag in serum), active or chronic hepatitis C infection (positive for serum antibodies against HCV), active tuberculosis.\n11. Pleuritis with pleural effusion of clinical relevance (≥ grade 2 according to the CTCAE v4.03).\n12. Pericarditis with pericardial effusion of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n13. Chronic or acute renal impairment with an eGFR of < 30 ml/min/1.73 m2 (calculated GFR using the MDRD formula with modification for race) or oliguria.\n14. Severe impairment of liver function with elevated plasma levels of bilirubin of ≥ 2 mg/dl or an INR of ≥ 1.7.\n15. Patients with diagnosis of type-1 diabetes mellitus or of Crohn´s Disease.\n16. Patients with inadequately controlled type-2 diabetes mellitus (HbA1c >9%) or patients with type-2 diabetes mellitus and history of recurrent hyperglycemia or hypoglycemia of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n17. Patients who received allogeneic solid organ transplants, except patients who underwent an autologous or allogeneic hematopoetic stem-cell transplantation (HSCT) more than two years prior to the screening visit (Visit 1) and who did not develop graft-versus-host disease (GvHD).\n18. Patients with diagnosis of malignant neoplasm or treatment for malignant neoplasm within the last 5 years prior to the screening visit (Visit 1), except adequately treated basal cell carcinoma or squamous cell carcinoma of the skin and carcinoma in situ of the uterine cervix.\n19. Patients with severe impairment of pulmonary function: severe restrictive lung disease with FVC of <50% of predicted value or obstructive lung disease with FEV1 of <50% of predicted value or O2-saturation of <90% determined by a pulse oxymeter under room air and in resting position.\n20. Severe cardiomyopathy or chronic heart failure with an ejection fraction of <30% or of ≥ grade 3 according to the CTCAE v4.03; instable angina pectoris; coronary heart disease with previous stent implantation within the last 3 month prior to the screening visit (Visit 1) or with three-vessel involvement; cardiac intervention or myocardial infarction within the last 12 month prior to the screening visit (Visit1); history of cardiac arrest.\n21. Cardiac arrhythmias of clinical relevance or requiring permanent treatment (≥ grade 2 according to the CTCAE v4.03); persistent or permanent atrial fibrillation; disturbance of transmission of impulses of clinical relevance (AV-Block >1°).\n22. Valvular heart disease of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n23. Patients with inadequately controlled permanently abnormal heart rate with <45 or >120 beats per minute in resting position.\n24. Patients with inadequately controlled permanent hypotension with systolic blood pressure <100 mmHG or diastolic blood pressure <50 mmHG in resting position.\n25. Patients with inadequately controlled permanent hypertension with systolic blood pressure >160 mmHG or diastolic blood pressure >100 mmHG in resting position.\n26. History of orthostatic dysregulation, fainting, or blackouts within the last 3 month prior to the screening visit (Visit 1).\n27. History of chronic organic psychosis or endogenous psychosis (schizophrenia, mania, bipolar disorder), except mild and transient forms of depression.\n28. History of seizures within the last 6 month prior to the screening visit (Visit 1).\n29. Treatment with Rituximab or any B cell depleting therapy within the last 6 months prior to the screening visit (Visit 1).\n30. Treatment with calcineurin-inhibitors (ciclosporin A, sirolimus, tacrolimus), cyclophosphamide, methotrexate (MTX) or Belimumab within the last 4 weeks prior to the baseline visit (Visit 2).\n31. Treatment with antiproliferative, cytostatic or cytotoxic agents within the last 4 weeks prior to the baseline visit (Visit 2) with the exception of permitted concomitant SLE-related medications.\n32. Treatment with alpha and beta-interferons within the last 4 weeks prior to the baseline visit (Visit 2).\n33. Experimental therapy or participation in another clinical study with investigational medicinal products within the last three month prior to the baseline visit (Visit 2).\n34. Necessity for application of radiographic iodinated contrast media during and 2 weeks after the completion of the last (4th) treatment cycle.\n35. Live vaccination within the last 4 weeks prior to the baseline visit (Visit 2), or plan to receive a live vaccine during study participation.\n36. Major surgery within the last 4 weeks prior to the screening visit (Visit 1) or plan to have elective major surgery during study participation.\n37. Pregnancy and lactating women.\n38. Lack of ability or willingness to practice reliable methods of contraception during the study (female and male participants).\n39. Abuse of alcohol or drugs.\n40. Lack of willingness for storage and transmission of pseudonymized medical data obtained during the clinical study\n41. Minors and subjects who are incapable to provide informed consent or who are considered to be incapable of adhering to the protocol and visit schedule and to be unable to comply with all study requirements according to the judgment of the investigator (according to AMG § 42(2) and (3)).\n42. Subjects kept in detention due to judicial or official order (according to AMG § 40 (1) 4).\n""]","[""The primary endpoint is defined by the increase in the percentage of\nCD25++ cells among CD3+CD4+Foxp3+CD127lo Treg cells by at least\n100% (2-fold) at week 9 (Visit 9; after the 4th treatment cycle)\ncompared to baseline at week 1 (Visit 2; before the 1st treatment cycle).\n\nSafety and tolerability will be evaluated descriptively by assessment of\nthe incidence, frequency, duration, severity and causal relationship to\nthe study medication of any adverse event (clinical and laboratory\ntestings) at every scheduled visit after the screening visit and at every\nunscheduled visit""]","[""• Changes in serum antibody titers for anti-dsDNA-Abs determined by ELISA and by the Crithidia luciliae IFT, serum levels of the complement factors C3 and C4 and serum levels of circulating immune complexes at week 9 (Visit 9) compared to baseline at week 1 (Visit 2)\n• Changes in serum antibody titers for ANA, ENA, anti-SmD1-Abs and other individually relevant serological markers, which were present at baseline or at previous examinations, at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in the disease activity scores SELENA-SLEDAI and BILAG 2004, and changes in PGA and VAS at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in health related Quality of Life (SF36®) one day after the 4th therapeutic cycle (Visit 9; week 9) compared to baseline values (Visit 2; week 1).\n• Changes in organ specific parameters based on individual SLE manifestations either at week 9 (Visit 9) and/or during the follow-up period (weeks 12-18) compared to values obtained at the baseline visit (Visit 2; week 1) or during the screening period.\n• Changes in SLE-associated organ damage by the SLICC/ACR Damage Index one day after the 4th cycle (visit 9; week 9) and at the termination visit (Visit 11; week 18) compared to values at screening visit (Visit 1).\n• Assessment of the durability of clinical and serological responses in subjects who responded to the therapy by comparing values at the follow-up and termination visits (Visits 10 and 11; week 12 and 18) to values from week 9 (Visit 9) and to baseline values (Visit 2; week 1).\n• Assessment of incidence, frequency and severity of SLE flares throughout the whole study.\n""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie\nMr. Dr. med. Jens Humrich \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"",""Mr. Dr. med. Jens Humrich "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49 30 450613413\nFax: +49 30 450513928\nE-mail: jens.humrich at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450613413"",""Telephone:"",""Fax: +49 30 450513928"",""Fax:"",""E-mail: jens.humrich at charite.de"",""E-mail:"",""jens.humrich at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie\nMr. Dr. med. Jens Humrich \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"",""Mr. Dr. med. Jens Humrich "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49 30 450613413\nFax: +49 30 450513928\nE-mail: jens.humrich at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450613413"",""Telephone:"",""Fax: +49 30 450513928"",""Fax:"",""E-mail: jens.humrich at charite.de"",""E-mail:"",""jens.humrich at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00004858,4,5,2015-04-16,Recruiting ongoing,2014-03-31,NA,12,Actual,18 Years,75 Years,"Both, male and female","[""Additional Inclusion Criteria"",""1. Patients with diagnosis of SLE made and documented by the investigator according to the revised ACR criteria fulfilling ≥ 4 criteria with at least one autoantibody level abnormal (ANA, anti-dsDNA-abs, anti-Sm-abs, anti-Phospholipid-abs).\n2. Active SLE patients with a SELENA-SLEDAI ≥ 6 despite previous treatment with at least two different standard immunosuppressive or immunomodulatory therapies.\n3. An EC approved written informed consent form signed and dated by the patient must be obtained prior to the performance of any protocol procedures and prior to the administration of the study medication (according to AMG §40 (1) 3b).\n4. Stable dosage of standard immunosuppressive or immunomodulatory treatments for at least 4 weeks prior to the first administration of the study medication.\n5. Daily dose of glucocorticosteroids must be ≤ 30mg prednisolone (or equivalent) at the day of baseline visit (Visit 2).\n6. Age of patients >18 years and ≤ 75 years.\n7. Willingness to perform blood analyses and to discontinue therapies which potentially interfere with the study medication.\n8. Female patients of childbearing potential must have a negative serological pregnancy test at the screening visit (Visit 1).\n9. Female patients of childbearing potential must use at least two reliable methods of birth control (1 of which is a barrier method) during study participation and up to 3 months after completion of the last (4th) treatment cycle.\n10. Male patients must agree to use a contraceptive barrier method (eg, condom) with adjunct spermicide during sexual intercourse from the time of the administration of the study medication until at least 3 month after completion of the last (4th) treatment cycle.\n""]","[""Exclusion Criteria"",""1. Hypersensibility to Aldesleukin or its excipients.\n2. Patients with a reduced general condition of 2 or more according to the ECOG (Eastern Cooperative Oncology Group) Performance Status.\n3. Severe impairment of vital organ or life-threatening disease.\n4. Thrombocytopenia with platelet count of <100.000/µl.\n5. Leukocytopenia with WBC of <3.000/µl or neutropenia with a neutrophil count of <1.500/µl.\n6. Anemia with hemoglobin of <9.0 g/dl.\n7. History of thrombotic microangiopathy (TTP).\n8. History of thrombosis or thrombotic event (including venous thrombosis, pulmonary embolism, cortical sinus thrombosis, stroke, or arterial embolism causing digital gangrene or tissue necrosis) within the last 6 month prior to the screening visit (Visit 1).\n9. Infection requiring antibiotic therapy or infection requiring hospitalisation within the last 4 weeks prior to the baseline visit (Visit 2).\n10. Long-term chronically active infectious disease, HIV infection (positive serum antibodies against HIV1/2), active or chronic hepatitis B infection (positive for HBs-Ag in serum), active or chronic hepatitis C infection (positive for serum antibodies against HCV), active tuberculosis.\n11. Pleuritis with pleural effusion of clinical relevance (≥ grade 2 according to the CTCAE v4.03).\n12. Pericarditis with pericardial effusion of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n13. Chronic or acute renal impairment with an eGFR of < 30 ml/min/1.73 m2 (calculated GFR using the MDRD formula with modification for race) or oliguria.\n14. Severe impairment of liver function with elevated plasma levels of bilirubin of ≥ 2 mg/dl or an INR of ≥ 1.7.\n15. Patients with diagnosis of type-1 diabetes mellitus or of Crohn´s Disease.\n16. Patients with inadequately controlled type-2 diabetes mellitus (HbA1c >9%) or patients with type-2 diabetes mellitus and history of recurrent hyperglycemia or hypoglycemia of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n17. Patients who received allogeneic solid organ transplants, except patients who underwent an autologous or allogeneic hematopoetic stem-cell transplantation (HSCT) more than two years prior to the screening visit (Visit 1) and who did not develop graft-versus-host disease (GvHD).\n18. Patients with diagnosis of malignant neoplasm or treatment for malignant neoplasm within the last 5 years prior to the screening visit (Visit 1), except adequately treated basal cell carcinoma or squamous cell carcinoma of the skin and carcinoma in situ of the uterine cervix.\n19. Patients with severe impairment of pulmonary function: severe restrictive lung disease with FVC of <50% of predicted value or obstructive lung disease with FEV1 of <50% of predicted value or O2-saturation of <90% determined by a pulse oxymeter under room air and in resting position.\n20. Severe cardiomyopathy or chronic heart failure with an ejection fraction of <30% or of ≥ grade 3 according to the CTCAE v4.03; instable angina pectoris; coronary heart disease with previous stent implantation within the last 3 month prior to the screening visit (Visit 1) or with three-vessel involvement; cardiac intervention or myocardial infarction within the last 12 month prior to the screening visit (Visit1); history of cardiac arrest.\n21. Cardiac arrhythmias of clinical relevance or requiring permanent treatment (≥ grade 2 according to the CTCAE v4.03); persistent or permanent atrial fibrillation; disturbance of transmission of impulses of clinical relevance (AV-Block >1°).\n22. Valvular heart disease of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n23. Patients with inadequately controlled permanently abnormal heart rate with <45 or >120 beats per minute in resting position.\n24. Patients with inadequately controlled permanent hypotension with systolic blood pressure <100 mmHG or diastolic blood pressure <50 mmHG in resting position.\n25. Patients with inadequately controlled permanent hypertension with systolic blood pressure >160 mmHG or diastolic blood pressure >100 mmHG in resting position.\n26. History of orthostatic dysregulation, fainting, or blackouts within the last 3 month prior to the screening visit (Visit 1).\n27. History of chronic organic psychosis or endogenous psychosis (schizophrenia, mania, bipolar disorder), except mild and transient forms of depression.\n28. History of seizures within the last 6 month prior to the screening visit (Visit 1).\n29. Treatment with Rituximab or any B cell depleting therapy within the last 6 months prior to the screening visit (Visit 1).\n30. Treatment with calcineurin-inhibitors (ciclosporin A, sirolimus, tacrolimus), cyclophosphamide, methotrexate (MTX) or Belimumab within the last 4 weeks prior to the baseline visit (Visit 2).\n31. Treatment with antiproliferative, cytostatic or cytotoxic agents within the last 4 weeks prior to the baseline visit (Visit 2) with the exception of permitted concomitant SLE-related medications.\n32. Treatment with alpha and beta-interferons within the last 4 weeks prior to the baseline visit (Visit 2).\n33. Experimental therapy or participation in another clinical study with investigational medicinal products within the last three month prior to the baseline visit (Visit 2).\n34. Necessity for application of radiographic iodinated contrast media during and 2 weeks after the completion of the last (4th) treatment cycle.\n35. Live vaccination within the last 4 weeks prior to the baseline visit (Visit 2), or plan to receive a live vaccine during study participation.\n36. Major surgery within the last 4 weeks prior to the screening visit (Visit 1) or plan to have elective major surgery during study participation.\n37. Pregnancy and lactating women.\n38. Lack of ability or willingness to practice reliable methods of contraception during the study (female and male participants).\n39. Abuse of alcohol or drugs.\n40. Lack of willingness for storage and transmission of pseudonymized medical data obtained during the clinical study\n41. Minors and subjects who are incapable to provide informed consent or who are considered to be incapable of adhering to the protocol and visit schedule and to be unable to comply with all study requirements according to the judgment of the investigator (according to AMG § 42(2) and (3)).\n42. Subjects kept in detention due to judicial or official order (according to AMG § 40 (1) 4).\n""]","[""The primary endpoint is defined by the increase in the percentage of\nCD25++ cells among CD3+CD4+Foxp3+CD127lo Treg cells by at least\n100% (2-fold) at week 9 (Visit 9; after the 4th treatment cycle)\ncompared to baseline at week 1 (Visit 2; before the 1st treatment cycle).\n\nSafety and tolerability will be evaluated descriptively by assessment of\nthe incidence, frequency, duration, severity and causal relationship to\nthe study medication of any adverse event (clinical and laboratory\ntestings) at every scheduled visit after the screening visit and at every\nunscheduled visit""]","[""• Changes in serum antibody titers for anti-dsDNA-Abs determined by ELISA and by the Crithidia luciliae IFT, serum levels of the complement factors C3 and C4 and serum levels of circulating immune complexes at week 9 (Visit 9) compared to baseline at week 1 (Visit 2)\n• Changes in serum antibody titers for ANA, ENA, anti-SmD1-Abs and other individually relevant serological markers, which were present at baseline or at previous examinations, at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in the disease activity scores SELENA-SLEDAI and BILAG 2004, and changes in PGA and VAS at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in health related Quality of Life (SF36®) one day after the 4th therapeutic cycle (Visit 9; week 9) compared to baseline values (Visit 2; week 1).\n• Changes in organ specific parameters based on individual SLE manifestations either at week 9 (Visit 9) and/or during the follow-up period (weeks 12-18) compared to values obtained at the baseline visit (Visit 2; week 1) or during the screening period.\n• Changes in SLE-associated organ damage by the SLICC/ACR Damage Index one day after the 4th cycle (visit 9; week 9) and at the termination visit (Visit 11; week 18) compared to values at screening visit (Visit 1).\n• Assessment of the durability of clinical and serological responses in subjects who responded to the therapy by comparing values at the follow-up and termination visits (Visits 10 and 11; week 12 and 18) to values from week 9 (Visit 9) and to baseline values (Visit 2; week 1).\n• Assessment of incidence, frequency and severity of SLE flares throughout the whole study.\n""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie\nMr. Dr. med. Jens Humrich \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"",""Mr. Dr. med. Jens Humrich "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49 30 450613413\nFax: +49 30 450513928\nE-mail: jens.humrich at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450613413"",""Telephone:"",""Fax: +49 30 450513928"",""Fax:"",""E-mail: jens.humrich at charite.de"",""E-mail:"",""jens.humrich at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie\nMr. Dr. med. Jens Humrich \nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie"",""Mr. Dr. med. Jens Humrich "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: +49 30 450613413\nFax: +49 30 450513928\nE-mail: jens.humrich at charite.de\nURL: http://www.charite.de"",""Telephone: +49 30 450613413"",""Telephone:"",""Fax: +49 30 450513928"",""Fax:"",""E-mail: jens.humrich at charite.de"",""E-mail:"",""jens.humrich at charite.de"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de""]"
DRKS00004858,5,5,2016-11-22,"Recruiting complete, follow-up complete",2014-03-31,2016-10-20,12,Actual,18 Years,75 Years,"Both, male and female","[""Additional Inclusion Criteria"",""1. Patients with diagnosis of SLE made and documented by the investigator according to the revised ACR criteria fulfilling ≥ 4 criteria with at least one autoantibody level abnormal (ANA, anti-dsDNA-abs, anti-Sm-abs, anti-Phospholipid-abs).\n2. Active SLE patients with a SELENA-SLEDAI ≥ 6 despite previous treatment with at least two different standard immunosuppressive or immunomodulatory therapies.\n3. An EC approved written informed consent form signed and dated by the patient must be obtained prior to the performance of any protocol procedures and prior to the administration of the study medication (according to AMG §40 (1) 3b).\n4. Stable dosage of standard immunosuppressive or immunomodulatory treatments for at least 4 weeks prior to the first administration of the study medication.\n5. Daily dose of glucocorticosteroids must be ≤ 30mg prednisolone (or equivalent) at the day of baseline visit (Visit 2).\n6. Age of patients >18 years and ≤ 75 years.\n7. Willingness to perform blood analyses and to discontinue therapies which potentially interfere with the study medication.\n8. Female patients of childbearing potential must have a negative serological pregnancy test at the screening visit (Visit 1).\n9. Female patients of childbearing potential must use at least two reliable methods of birth control (1 of which is a barrier method) during study participation and up to 3 months after completion of the last (4th) treatment cycle.\n10. Male patients must agree to use a contraceptive barrier method (eg, condom) with adjunct spermicide during sexual intercourse from the time of the administration of the study medication until at least 3 month after completion of the last (4th) treatment cycle.\n""]","[""Exclusion Criteria"",""1. Hypersensibility to Aldesleukin or its excipients.\n2. Patients with a reduced general condition of 2 or more according to the ECOG (Eastern Cooperative Oncology Group) Performance Status.\n3. Severe impairment of vital organ or life-threatening disease.\n4. Thrombocytopenia with platelet count of <100.000/µl.\n5. Leukocytopenia with WBC of <3.000/µl or neutropenia with a neutrophil count of <1.500/µl.\n6. Anemia with hemoglobin of <9.0 g/dl.\n7. History of thrombotic microangiopathy (TTP).\n8. History of thrombosis or thrombotic event (including venous thrombosis, pulmonary embolism, cortical sinus thrombosis, stroke, or arterial embolism causing digital gangrene or tissue necrosis) within the last 6 month prior to the screening visit (Visit 1).\n9. Infection requiring antibiotic therapy or infection requiring hospitalisation within the last 4 weeks prior to the baseline visit (Visit 2).\n10. Long-term chronically active infectious disease, HIV infection (positive serum antibodies against HIV1/2), active or chronic hepatitis B infection (positive for HBs-Ag in serum), active or chronic hepatitis C infection (positive for serum antibodies against HCV), active tuberculosis.\n11. Pleuritis with pleural effusion of clinical relevance (≥ grade 2 according to the CTCAE v4.03).\n12. Pericarditis with pericardial effusion of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n13. Chronic or acute renal impairment with an eGFR of < 30 ml/min/1.73 m2 (calculated GFR using the MDRD formula with modification for race) or oliguria.\n14. Severe impairment of liver function with elevated plasma levels of bilirubin of ≥ 2 mg/dl or an INR of ≥ 1.7.\n15. Patients with diagnosis of type-1 diabetes mellitus or of Crohn´s Disease.\n16. Patients with inadequately controlled type-2 diabetes mellitus (HbA1c >9%) or patients with type-2 diabetes mellitus and history of recurrent hyperglycemia or hypoglycemia of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n17. Patients who received allogeneic solid organ transplants, except patients who underwent an autologous or allogeneic hematopoetic stem-cell transplantation (HSCT) more than two years prior to the screening visit (Visit 1) and who did not develop graft-versus-host disease (GvHD).\n18. Patients with diagnosis of malignant neoplasm or treatment for malignant neoplasm within the last 5 years prior to the screening visit (Visit 1), except adequately treated basal cell carcinoma or squamous cell carcinoma of the skin and carcinoma in situ of the uterine cervix.\n19. Patients with severe impairment of pulmonary function: severe restrictive lung disease with FVC of <50% of predicted value or obstructive lung disease with FEV1 of <50% of predicted value or O2-saturation of <90% determined by a pulse oxymeter under room air and in resting position.\n20. Severe cardiomyopathy or chronic heart failure with an ejection fraction of <30% or of ≥ grade 3 according to the CTCAE v4.03; instable angina pectoris; coronary heart disease with previous stent implantation within the last 3 month prior to the screening visit (Visit 1) or with three-vessel involvement; cardiac intervention or myocardial infarction within the last 12 month prior to the screening visit (Visit1); history of cardiac arrest.\n21. Cardiac arrhythmias of clinical relevance or requiring permanent treatment (≥ grade 2 according to the CTCAE v4.03); persistent or permanent atrial fibrillation; disturbance of transmission of impulses of clinical relevance (AV-Block >1°).\n22. Valvular heart disease of clinical relevance (≥ grade 3 according to the CTCAE v4.03).\n23. Patients with inadequately controlled permanently abnormal heart rate with <45 or >120 beats per minute in resting position.\n24. Patients with inadequately controlled permanent hypotension with systolic blood pressure <100 mmHG or diastolic blood pressure <50 mmHG in resting position.\n25. Patients with inadequately controlled permanent hypertension with systolic blood pressure >160 mmHG or diastolic blood pressure >100 mmHG in resting position.\n26. History of orthostatic dysregulation, fainting, or blackouts within the last 3 month prior to the screening visit (Visit 1).\n27. History of chronic organic psychosis or endogenous psychosis (schizophrenia, mania, bipolar disorder), except mild and transient forms of depression.\n28. History of seizures within the last 6 month prior to the screening visit (Visit 1).\n29. Treatment with Rituximab or any B cell depleting therapy within the last 6 months prior to the screening visit (Visit 1).\n30. Treatment with calcineurin-inhibitors (ciclosporin A, sirolimus, tacrolimus), cyclophosphamide, methotrexate (MTX) or Belimumab within the last 4 weeks prior to the baseline visit (Visit 2).\n31. Treatment with antiproliferative, cytostatic or cytotoxic agents within the last 4 weeks prior to the baseline visit (Visit 2) with the exception of permitted concomitant SLE-related medications.\n32. Treatment with alpha and beta-interferons within the last 4 weeks prior to the baseline visit (Visit 2).\n33. Experimental therapy or participation in another clinical study with investigational medicinal products within the last three month prior to the baseline visit (Visit 2).\n34. Necessity for application of radiographic iodinated contrast media during and 2 weeks after the completion of the last (4th) treatment cycle.\n35. Live vaccination within the last 4 weeks prior to the baseline visit (Visit 2), or plan to receive a live vaccine during study participation.\n36. Major surgery within the last 4 weeks prior to the screening visit (Visit 1) or plan to have elective major surgery during study participation.\n37. Pregnancy and lactating women.\n38. Lack of ability or willingness to practice reliable methods of contraception during the study (female and male participants).\n39. Abuse of alcohol or drugs.\n40. Lack of willingness for storage and transmission of pseudonymized medical data obtained during the clinical study\n41. Minors and subjects who are incapable to provide informed consent or who are considered to be incapable of adhering to the protocol and visit schedule and to be unable to comply with all study requirements according to the judgment of the investigator (according to AMG § 42(2) and (3)).\n42. Subjects kept in detention due to judicial or official order (according to AMG § 40 (1) 4).\n""]","[""The primary endpoint is defined by the increase in the percentage of\nCD25++ cells among CD3+CD4+Foxp3+CD127lo Treg cells by at least\n100% (2-fold) at week 9 (Visit 9; after the 4th treatment cycle)\ncompared to baseline at week 1 (Visit 2; before the 1st treatment cycle).\n\nSafety and tolerability will be evaluated descriptively by assessment of\nthe incidence, frequency, duration, severity and causal relationship to\nthe study medication of any adverse event (clinical and laboratory\ntestings) at every scheduled visit after the screening visit and at every\nunscheduled visit""]","[""• Changes in serum antibody titers for anti-dsDNA-Abs determined by ELISA and by the Crithidia luciliae IFT, serum levels of the complement factors C3 and C4 and serum levels of circulating immune complexes at week 9 (Visit 9) compared to baseline at week 1 (Visit 2)\n• Changes in serum antibody titers for ANA, ENA, anti-SmD1-Abs and other individually relevant serological markers, which were present at baseline or at previous examinations, at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in the disease activity scores SELENA-SLEDAI and BILAG 2004, and changes in PGA and VAS at week 9 (Visit 9) compared to baseline at week 1 (Visit 2).\n• Changes in health related Quality of Life (SF36®) one day after the 4th therapeutic cycle (Visit 9; week 9) compared to baseline values (Visit 2; week 1).\n• Changes in organ specific parameters based on individual SLE manifestations either at week 9 (Visit 9) and/or during the follow-up period (weeks 12-18) compared to values obtained at the baseline visit (Visit 2; week 1) or during the screening period.\n• Changes in SLE-associated organ damage by the SLICC/ACR Damage Index one day after the 4th cycle (visit 9; week 9) and at the termination visit (Visit 11; week 18) compared to values at screening visit (Visit 1).\n• Assessment of the durability of clinical and serological responses in subjects who responded to the therapy by comparing values at the follow-up and termination visits (Visits 10 and 11; week 12 and 18) to values from week 9 (Visit 9) and to baseline values (Visit 2; week 1).\n• Assessment of incidence, frequency and severity of SLE flares throughout the whole study.\n""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Rheumatologie\nMr. Dr. med. Jens Humrich \nRatzeburger Allee 160\n23538 Lübeck\nGermany"",""Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Rheumatologie"",""Mr. Dr. med. Jens Humrich "",""Ratzeburger Allee 160"",""23538 Lübeck"",""Germany"",""Telephone: +49 451 50045203\nFax: +49 451 50045204\nE-mail: jens.humrich at uksh.de\nURL: http://www.uksh.de"",""Telephone: +49 451 50045203"",""Telephone:"",""Fax: +49 451 50045204"",""Fax:"",""E-mail: jens.humrich at uksh.de"",""E-mail:"",""jens.humrich at uksh.de"",""URL: http://www.uksh.de"",""URL:"",""http://www.uksh.de"",""Contact for Public Queries"",""Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Rheumatologie\nMr. Dr. med. Jens Humrich \nRatzeburger Allee 160\n23538 Lübeck\nGermany"",""Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Rheumatologie"",""Mr. Dr. med. Jens Humrich "",""Ratzeburger Allee 160"",""23538 Lübeck"",""Germany"",""Telephone: +49 451 50045203\nFax: +49 451 50045302\nE-mail: jens.humrich at uksh.de\nURL: http://www.uksh.de"",""Telephone: +49 451 50045203"",""Telephone:"",""Fax: +49 451 50045302"",""Fax:"",""E-mail: jens.humrich at uksh.de"",""E-mail:"",""jens.humrich at uksh.de"",""URL: http://www.uksh.de"",""URL:"",""http://www.uksh.de""]"
DRKS00009546,1,2,2015-11-09,Recruiting ongoing,2015-04-20,NA,60,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Informed consent from patient, age ≥ 18 years, cardiac surgery, no paritcipation in a drug trial, surgery under general anesthesia""]","[""Exclusion Criteria"",""No informed consent, patients unable to consent, pergnant or breast feeding women, emergency surgery, side difference of blood pressure > 12 mmHg, tissue ischemia, Severe peripheral arterial vascular occlusion disease ≥ 4 after Fontaine, atrial fibrillation, need of intra aortic balloon pump""]","[""Measurement of blood pressure (absolute and trending) by use of piezo-foil technology and invasively in the perioperative setting.""]","[""Measurement of pulse pressure and stroke volume variation by use of piezo-foil technology and invasively in the perioperative setting.""]","[""Primary Sponsor"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin\nMr. Dr. med. Sascha Treskatsch \nChariteplatz 1\n10117 Berlin\nGermany"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin"",""Mr. Dr. med. Sascha Treskatsch "",""Chariteplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030450531052\nFax: 030450531952\nE-mail: sascha.treskatsch at charite.de\nURL: http://anaesthesieintensivmedizin.charite.de"",""Telephone: 030450531052"",""Telephone:"",""Fax: 030450531952"",""Fax:"",""E-mail: sascha.treskatsch at charite.de"",""E-mail:"",""sascha.treskatsch at charite.de"",""URL: http://anaesthesieintensivmedizin.charite.de"",""URL:"",""http://anaesthesieintensivmedizin.charite.de"",""Collaborator, Other Address"",""SectorCon GmbH\nMr. Philipp Kaeferstein \nKaiserin-Augusta-Allee 10\n10553 Berlin\nGermany"",""SectorCon GmbH"",""Mr. Philipp Kaeferstein "",""Kaiserin-Augusta-Allee 10"",""10553 Berlin"",""Germany"",""Telephone: 03034794522\nFax: 030347945-29\nE-mail: philipp.kaeferstein at sector.de\nURL: http://www.sector.de"",""Telephone: 03034794522"",""Telephone:"",""Fax: 030347945-29"",""Fax:"",""E-mail: philipp.kaeferstein at sector.de"",""E-mail:"",""philipp.kaeferstein at sector.de"",""URL: http://www.sector.de"",""URL:"",""http://www.sector.de"",""Contact for Scientific Queries"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin\nMr. Dr. med. Sascha Treskatsch \nChariteplatz 1\n10117 Berlin\nGermany"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin"",""Mr. Dr. med. Sascha Treskatsch "",""Chariteplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030450531052\nFax: 030450531952\nE-mail: sascha.treskatsch at charite.de\nURL: http://anaesthesieintensivmedizin.charite.de"",""Telephone: 030450531052"",""Telephone:"",""Fax: 030450531952"",""Fax:"",""E-mail: sascha.treskatsch at charite.de"",""E-mail:"",""sascha.treskatsch at charite.de"",""URL: http://anaesthesieintensivmedizin.charite.de"",""URL:"",""http://anaesthesieintensivmedizin.charite.de"",""Contact for Public Queries"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin\nMr. Dr. med. Viktor Mezger \nCharitéplatz 1\n10117 Berlin\nGermany"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin"",""Mr. Dr. med. Viktor Mezger "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030450631177\nFax: 030450531911\nE-mail: viktor.mezger at charite.de\nURL: http://anaesthesieintensivmedizin.charite.de"",""Telephone: 030450631177"",""Telephone:"",""Fax: 030450531911"",""Fax:"",""E-mail: viktor.mezger at charite.de"",""E-mail:"",""viktor.mezger at charite.de"",""URL: http://anaesthesieintensivmedizin.charite.de"",""URL:"",""http://anaesthesieintensivmedizin.charite.de""]"
DRKS00009546,2,2,2018-05-03,"Recruiting complete, follow-up complete",2015-04-20,2016-03-26,60,Actual,18 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Informed consent from patient, age ≥ 18 years, cardiac surgery, no paritcipation in a drug trial, surgery under general anesthesia""]","[""Exclusion Criteria"",""No informed consent, patients unable to consent, pergnant or breast feeding women, emergency surgery, side difference of blood pressure > 12 mmHg, tissue ischemia, Severe peripheral arterial vascular occlusion disease ≥ 4 after Fontaine, atrial fibrillation, need of intra aortic balloon pump""]","[""Measurement of blood pressure (absolute and trending) by use of piezo-foil technology and invasively in the perioperative setting.""]","[""Measurement of pulse pressure and stroke volume variation by use of piezo-foil technology and invasively in the perioperative setting.""]","[""Primary Sponsor"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin\nMr. Dr. med. Sascha Treskatsch \nChariteplatz 1\n10117 Berlin\nGermany"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin"",""Mr. Dr. med. Sascha Treskatsch "",""Chariteplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030450531052\nFax: 030450531952\nE-mail: sascha.treskatsch at charite.de\nURL: http://anaesthesieintensivmedizin.charite.de"",""Telephone: 030450531052"",""Telephone:"",""Fax: 030450531952"",""Fax:"",""E-mail: sascha.treskatsch at charite.de"",""E-mail:"",""sascha.treskatsch at charite.de"",""URL: http://anaesthesieintensivmedizin.charite.de"",""URL:"",""http://anaesthesieintensivmedizin.charite.de"",""Collaborator, Other Address"",""SectorCon GmbH\nMr. Philipp Kaeferstein \nKaiserin-Augusta-Allee 10\n10553 Berlin\nGermany"",""SectorCon GmbH"",""Mr. Philipp Kaeferstein "",""Kaiserin-Augusta-Allee 10"",""10553 Berlin"",""Germany"",""Telephone: 03034794522\nFax: 030347945-29\nE-mail: philipp.kaeferstein at sector.de\nURL: http://www.sector.de"",""Telephone: 03034794522"",""Telephone:"",""Fax: 030347945-29"",""Fax:"",""E-mail: philipp.kaeferstein at sector.de"",""E-mail:"",""philipp.kaeferstein at sector.de"",""URL: http://www.sector.de"",""URL:"",""http://www.sector.de"",""Contact for Scientific Queries"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin\nMr. Dr. med. Sascha Treskatsch \nChariteplatz 1\n10117 Berlin\nGermany"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin"",""Mr. Dr. med. Sascha Treskatsch "",""Chariteplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030450531052\nFax: 030450531952\nE-mail: sascha.treskatsch at charite.de\nURL: http://anaesthesieintensivmedizin.charite.de"",""Telephone: 030450531052"",""Telephone:"",""Fax: 030450531952"",""Fax:"",""E-mail: sascha.treskatsch at charite.de"",""E-mail:"",""sascha.treskatsch at charite.de"",""URL: http://anaesthesieintensivmedizin.charite.de"",""URL:"",""http://anaesthesieintensivmedizin.charite.de"",""Contact for Public Queries"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin\nMr. Dr. med. Viktor Mezger \nCharitéplatz 1\n10117 Berlin\nGermany"",""Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin, Campus Charite Mitte und Virchow Klinikum, Charite - Universitätsmedizin Berlin"",""Mr. Dr. med. Viktor Mezger "",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: 030450631177\nFax: 030450531911\nE-mail: viktor.mezger at charite.de\nURL: http://anaesthesieintensivmedizin.charite.de"",""Telephone: 030450631177"",""Telephone:"",""Fax: 030450531911"",""Fax:"",""E-mail: viktor.mezger at charite.de"",""E-mail:"",""viktor.mezger at charite.de"",""URL: http://anaesthesieintensivmedizin.charite.de"",""URL:"",""http://anaesthesieintensivmedizin.charite.de""]"
DRKS00011552,1,8,2017-01-23,Recruiting ongoing,2017-01-30,NA,30,Planned,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Residents: 65 years and older, clinical diagnosis of dementia, independent, mobile, patient information and written informed consent available; caregiver: minimum 50% employment by the corresponding nursing home.""]","[""Exclusion Criteria"",""Residents: lack of verbal skills; caregivers: more than two months absence during study.""]","[""At the end of the intervention phase after 10 weeks; residents (external assessment by contact person (relative or caregiver) - life quality (Qualidem)""]","[""At the end of the intervention phase after 10 weeks and at the end of the follow-up phase after 14 weeks; caregiver: self developed questionnaire about sustainability - caregiver stress (ProQool); residents (external assessment by contact person (relative or caregiver) - self-developed questionnaire about sustainability - life qualita (Qualidem) - depression (Corenell Depression Scale (CDS)) - agitation (sub category of disruptive behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - social behaviur (sub category social behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - apathy (apathy evaluation scale (AES) - mobility (nursing home life spce diameter)""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/""]"
DRKS00011552,2,8,2017-05-24,Recruiting ongoing,2017-01-03,NA,30,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Residents: 65 years and older, clinical diagnosis of dementia, independent, mobile, patient information and written informed consent available; caregiver: minimum 50% employment by the corresponding nursing home.""]","[""Exclusion Criteria"",""Residents: lack of verbal skills; caregivers: more than two months absence during study.""]","[""At the end of the intervention phase after 10 weeks; residents (external assessment by contact person (relative or caregiver) - life quality (Qualidem)""]","[""At the end of the intervention phase after 10 weeks and at the end of the follow-up phase after 14 weeks; caregiver: self developed questionnaire about sustainability - caregiver stress (ProQool); residents (external assessment by contact person (relative or caregiver) - self-developed questionnaire about sustainability - life qualita (Qualidem) - depression (Corenell Depression Scale (CDS)) - agitation (sub category of disruptive behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - social behaviur (sub category social behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - apathy (apathy evaluation scale (AES) - mobility (nursing home life spce diameter)""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/""]"
DRKS00011552,3,8,2017-06-28,"Recruiting complete, follow-up complete",2017-01-03,2017-05-19,30,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Residents: 65 years and older, clinical diagnosis of dementia, independent, mobile, patient information and written informed consent available; caregiver: minimum 50% employment by the corresponding nursing home.""]","[""Exclusion Criteria"",""Residents: lack of verbal skills; caregivers: more than two months absence during study.""]","[""At the end of the intervention phase after 10 weeks; residents (external assessment by contact person (relative or caregiver) - life quality (Qualidem)""]","[""At the end of the intervention phase after 10 weeks and at the end of the follow-up phase after 14 weeks; caregiver: self developed questionnaire about sustainability - caregiver stress (ProQool); residents (external assessment by contact person (relative or caregiver) - self-developed questionnaire about sustainability - life qualita (Qualidem) - depression (Corenell Depression Scale (CDS)) - agitation (sub category of disruptive behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - social behaviur (sub category social behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - apathy (apathy evaluation scale (AES) - mobility (nursing home life spce diameter)""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/""]"
DRKS00011552,4,8,2018-01-04,"Recruiting complete, follow-up complete",2017-01-03,2017-05-19,30,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Residents: 65 years and older, clinical diagnosis of dementia, independent, mobile, patient information and written informed consent available; caregiver: minimum 50% employment by the corresponding nursing home.""]","[""Exclusion Criteria"",""Residents: lack of verbal skills; caregivers: more than two months absence during study.""]","[""At the end of the intervention phase after 10 weeks; residents (external assessment by contact person (relative or caregiver) - life quality (Qualidem)""]","[""At the end of the intervention phase after 10 weeks and at the end of the follow-up phase after 14 weeks; caregiver: self developed questionnaire about sustainability - caregiver stress (ProQool); residents (external assessment by contact person (relative or caregiver) - self-developed questionnaire about sustainability - life qualita (Qualidem) - depression (Corenell Depression Scale (CDS)) - agitation (sub category of disruptive behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - social behaviur (sub category social behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - apathy (apathy evaluation scale (AES) - mobility (nursing home life spce diameter)""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/""]"
DRKS00011552,5,8,2018-04-26,"Recruiting complete, follow-up complete",2017-01-03,2017-05-19,30,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Residents: 65 years and older, clinical diagnosis of dementia, independent, mobile, patient information and written informed consent available; caregiver: minimum 50% employment by the corresponding nursing home.""]","[""Exclusion Criteria"",""Residents: lack of verbal skills; caregivers: more than two months absence during study.""]","[""At the end of the intervention phase after 10 weeks; residents (external assessment by contact person (relative or caregiver) - life quality (Qualidem)""]","[""At the end of the intervention phase after 10 weeks and at the end of the follow-up phase after 14 weeks; caregiver: self developed questionnaire about sustainability - caregiver stress (ProQool); residents (external assessment by contact person (relative or caregiver) - self-developed questionnaire about sustainability - life qualita (Qualidem) - depression (Corenell Depression Scale (CDS)) - agitation (sub category of disruptive behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - social behaviur (sub category social behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - apathy (apathy evaluation scale (AES) - mobility (nursing home life spce diameter)""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/""]"
DRKS00011552,6,8,2019-01-16,"Recruiting complete, follow-up complete",2017-01-03,2017-05-19,30,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Residents: 65 years and older, clinical diagnosis of dementia, independent, mobile, patient information and written informed consent available; caregiver: minimum 50% employment by the corresponding nursing home.""]","[""Exclusion Criteria"",""Residents: lack of verbal skills; caregivers: more than two months absence during study.""]","[""At the end of the intervention phase after 10 weeks; residents (external assessment by contact person (relative or caregiver) - life quality (Qualidem)""]","[""At the end of the intervention phase after 10 weeks and at the end of the follow-up phase after 14 weeks; caregiver: self developed questionnaire about sustainability - caregiver stress (ProQool); residents (external assessment by contact person (relative or caregiver) - self-developed questionnaire about sustainability - life qualita (Qualidem) - depression (Corenell Depression Scale (CDS)) - agitation (sub category of disruptive behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - social behaviur (sub category social behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - apathy (apathy evaluation scale (AES) - mobility (nursing home life spce diameter)""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/""]"
DRKS00011552,7,8,2020-01-27,"Recruiting complete, follow-up complete",2017-01-03,2017-05-19,30,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Residents: 65 years and older, clinical diagnosis of dementia, independent, mobile, patient information and written informed consent available; caregiver: minimum 50% employment by the corresponding nursing home.""]","[""Exclusion Criteria"",""Residents: lack of verbal skills; caregivers: more than two months absence during study.""]","[""At the end of the intervention phase after 10 weeks; residents (external assessment by contact person (relative or caregiver) - life quality (Qualidem)""]","[""At the end of the intervention phase after 10 weeks and at the end of the follow-up phase after 14 weeks; caregiver: self developed questionnaire about sustainability - caregiver stress (ProQool); residents (external assessment by contact person (relative or caregiver) - self-developed questionnaire about sustainability - life qualita (Qualidem) - depression (Corenell Depression Scale (CDS)) - agitation (sub category of disruptive behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - social behaviur (sub category social behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - apathy (apathy evaluation scale (AES) - mobility (nursing home life spce diameter)""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/""]"
DRKS00011552,8,8,2020-08-11,"Recruiting complete, follow-up complete",2017-01-03,2017-05-19,30,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""Residents: 65 years and older, clinical diagnosis of dementia, independent, mobile, patient information and written informed consent available; caregiver: minimum 50% employment by the corresponding nursing home.""]","[""Exclusion Criteria"",""Residents: lack of verbal skills; caregivers: more than two months absence during study.""]","[""At the end of the intervention phase after 10 weeks; residents (external assessment by contact person (relative or caregiver) - life quality (Qualidem)""]","[""At the end of the intervention phase after 10 weeks and at the end of the follow-up phase after 14 weeks; caregiver: self developed questionnaire about sustainability - caregiver stress (ProQool); residents (external assessment by contact person (relative or caregiver) - self-developed questionnaire about sustainability - life qualita (Qualidem) - depression (Corenell Depression Scale (CDS)) - agitation (sub category of disruptive behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - social behaviur (sub category social behaviour from the nurses' observation scale for geriatric patients (NOSGER)) - apathy (apathy evaluation scale (AES) - mobility (nursing home life spce diameter)""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik\nMs. Rebecca Dahms \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie, Arbeitsgruppe Alter & Technik"",""Ms. Rebecca Dahms "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 696\nFax: +49 30 450 7553 696\nE-mail: rebecca.dahms at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 696"",""Telephone:"",""Fax: +49 30 450 7553 696"",""Fax:"",""E-mail: rebecca.dahms at charite.de"",""E-mail:"",""rebecca.dahms at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/""]"
DRKS00011584,1,5,2017-02-20,Recruiting planned,2017-04-03,NA,16,Planned,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- subjective memory performance problems - participant information and written consent""]","[""Exclusion Criteria"",""- serious affective or cognitive disorders (query psychiatric treatment) - legal supervision""]","[""Subjective collection of stressors and coping strategies within the daily lives of the participants by a standardised self-monitoring protocol for four weeks, starting at the end of visit 1.""]","[""1. Impact of an assistive system aimed at supporting persons with cognitive impairments: the validated questionnaire about subjective memory performance (MAC-S) and the cognition test evaluating the performance of the episodic memory (learn word list and retrieve word list) will be conducted. 2. Analysis of human-machine-interaction (usability analysis) of seniors with a Smart Glass: the participants will be asked about the usage of the system and they will be asked to evaluate the usability of the system (questionnaire \""usage and usability\"").""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00011584,2,5,2017-05-24,Recruiting ongoing,2017-03-28,NA,16,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- subjective memory performance problems - participant information and written consent""]","[""Exclusion Criteria"",""- serious affective or cognitive disorders (query psychiatric treatment) - legal supervision""]","[""Subjective collection of stressors and coping strategies within the daily lives of the participants by a standardised self-monitoring protocol for four weeks, starting at the end of visit 1.""]","[""1. Impact of an assistive system aimed at supporting persons with cognitive impairments: the validated questionnaire about subjective memory performance (MAC-S) and the cognition test evaluating the performance of the episodic memory (learn word list and retrieve word list) will be conducted. 2. Analysis of human-machine-interaction (usability analysis) of seniors with a Smart Glass: the participants will be asked about the usage of the system and they will be asked to evaluate the usability of the system (questionnaire \""usage and usability\"").""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00011584,3,5,2017-06-28,"Recruiting complete, follow-up continuing",2017-03-28,NA,16,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- subjective memory performance problems - participant information and written consent""]","[""Exclusion Criteria"",""- serious affective or cognitive disorders (query psychiatric treatment) - legal supervision""]","[""Subjective collection of stressors and coping strategies within the daily lives of the participants by a standardised self-monitoring protocol for four weeks, starting at the end of visit 1.""]","[""1. Impact of an assistive system aimed at supporting persons with cognitive impairments: the validated questionnaire about subjective memory performance (MAC-S) and the cognition test evaluating the performance of the episodic memory (learn word list and retrieve word list) will be conducted. 2. Analysis of human-machine-interaction (usability analysis) of seniors with a Smart Glass: the participants will be asked about the usage of the system and they will be asked to evaluate the usability of the system (questionnaire \""usage and usability\"").""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00011584,4,5,2018-01-04,"Recruiting complete, follow-up complete",2017-03-28,2017-10-31,16,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- subjective memory performance problems - participant information and written consent""]","[""Exclusion Criteria"",""- serious affective or cognitive disorders (query psychiatric treatment) - legal supervision""]","[""Subjective collection of stressors and coping strategies within the daily lives of the participants by a standardised self-monitoring protocol for four weeks, starting at the end of visit 1.""]","[""1. Impact of an assistive system aimed at supporting persons with cognitive impairments: the validated questionnaire about subjective memory performance (MAC-S) and the cognition test evaluating the performance of the episodic memory (learn word list and retrieve word list) will be conducted. 2. Analysis of human-machine-interaction (usability analysis) of seniors with a Smart Glass: the participants will be asked about the usage of the system and they will be asked to evaluate the usability of the system (questionnaire \""usage and usability\"").""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00011584,5,5,2019-07-09,"Recruiting complete, follow-up complete",2017-03-28,2017-10-31,16,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- subjective memory performance problems - participant information and written consent""]","[""Exclusion Criteria"",""- serious affective or cognitive disorders (query psychiatric treatment) - legal supervision""]","[""Subjective collection of stressors and coping strategies within the daily lives of the participants by a standardised self-monitoring protocol for four weeks, starting at the end of visit 1.""]","[""1. Impact of an assistive system aimed at supporting persons with cognitive impairments: the validated questionnaire about subjective memory performance (MAC-S) and the cognition test evaluating the performance of the episodic memory (learn word list and retrieve word list) will be conducted. 2. Analysis of human-machine-interaction (usability analysis) of seniors with a Smart Glass: the participants will be asked about the usage of the system and they will be asked to evaluate the usability of the system (questionnaire \""usage and usability\"").""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. rer. medic. Anika Steinert \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. rer. medic. Anika Steinert "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,1,11,2017-09-06,Recruiting ongoing,2017-08-21,NA,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,2,11,2018-06-14,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,3,11,2018-12-14,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,4,11,2019-06-19,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,5,11,2019-12-21,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,6,11,2020-04-24,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,7,11,2020-05-19,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,8,11,2020-06-09,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,9,11,2020-07-27,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,10,11,2020-10-15,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00012665,11,11,2020-10-15,"Recruiting complete, follow-up complete",2017-08-21,2017-09-15,50,Actual,65 Years,no maximum age,"Both, male and female","[""Additional Inclusion Criteria"",""- age ≥ 65 years\n- presence of subjects' information and signed consent""]","[""Exclusion Criteria"",""- severe cognitive disorders\n- psychiatric disorders\n- severe auditory, visual, speech, sensory and motor impairments\n- severe system diseases\n- persistent mild or severe pain\n- CNS diseases and diseases that affect the CNS\n- cerebro-vascular diseases\n- legal representatives\n- current study participation""]","[""\nDuration (TMT-A, TMT-B) and number of errros (Stroop test) in digital assesments in comparison to Duration and number of Errors in paper-based assessments\n""]","[""Acceptance and usability of digital cognitive assessments measured by System usability scale und three Sub scales (Stimulation, readability and efficiancy) of user experience questionnaire""]","[""Primary Sponsor"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie\nMs. Dr. Anika Steinert \nReinickendorfer Str. 61\n13347 Berlin\nGermany"",""Charité - Universitätsmedizin Berlin, Forschungsgruppe Geriatrie"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Str. 61"",""13347 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: anika.steinert at charite.de\nURL: [---]*"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: [---]*"",""URL:"",""Contact for Scientific Queries"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin\nMs. Dr. Anika Steinert \nReinickendorfer Straße 61\n13347 Berlin\nGermany"",""Forschungsgruppe GeriatrieCharité - Universitätsmedizin Berlin"",""Ms. Dr. Anika Steinert "",""Reinickendorfer Straße 61"",""13347 Berlin"",""Germany"",""Telephone: +49 30 450 553 736\nFax: +49 30 450 7553 736\nE-mail: anika.steinert at charite.de\nURL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Telephone: +49 30 450 553 736"",""Telephone:"",""Fax: +49 30 450 7553 736"",""Fax:"",""E-mail: anika.steinert at charite.de"",""E-mail:"",""anika.steinert at charite.de"",""URL: https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""URL:"",""https://geriatrie.charite.de/institut/arbeitsgruppen/ag_alter_technik/"",""Contact for Public Queries"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin\nMs. Lina Runde \nReinickendorferstr. 61\n13347 Berlin\nGermany"",""Forschungsgruppe Geriatrie Charité-Universitätsmedizin Berlin"",""Ms. Lina Runde "",""Reinickendorferstr. 61"",""13347 Berlin"",""Germany"",""Telephone: 030450553736\nFax: [---]*\nE-mail: lina.runde at charite.de\nURL: [---]*"",""Telephone: 030450553736"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: lina.runde at charite.de"",""E-mail:"",""lina.runde at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00005219,1,2,2014-02-17,Recruiting ongoing,2013-08-09,NA,48,Actual,18 Years,35 Years,Male,"[""Additional Inclusion Criteria"",""- Men\n- 18 - 35 years\n- Written consent (according to AMG § 40 (1) 3b)\n- Good knowledge of German\n- right-handedness\n""]","[""Exclusion Criteria"",""- Known hypersensitivity to the study medication\n- All contraindications to the study medication: arrhythmia, hyperthyroidism , glaucoma , pheochromocytoma , congestive heart failure , diabetes mellitus, known liver and kidney dysfunction, vascular disease , angina, haemodynamically significant congenital heart disease , cardiomyopathy , myocardial infarction, channelopathies, arterial hypertension , cerebrovascular diseases , such as cerebral aneurysm , vascular abnormalities , including vasculitis and stroke.\n- Participation in other clinical trials during or within one month prior to this clinical trial\n- Medical or psychological circumstances that may endanger the proper conduct of the trial\n- Existing serious somatic diseases, even if they are not covered by the contraindications according to product information\n- Existing psychiatric disorders and psychiatric disorders in prehistory\n- Smoker or ex-smoker for less than 5 years\n- Regular caffeine consumption > 4 cups per day\n- Subjects with irregular day -night rhythm (eg shift workers )\n- Unwillingness to the storage and disclosure of pseudonymous data as part of the clinical trial\n- Accommodation in an institution by court or administrative order (according to AMG § 40 (1) 4 )\n- MR contraindications ( eg pacemakers , metallic or electronic implants , metallic splinters , tinnitus, surgical clips )\n""]","[""Resting state Parameters from fMRI- ReHo (regional homogeneity) and ALFF (amplitude of low frequency fluctuation)- to be messured once, 1h after drug intake""]","[""Performance in neuropsychological testing (BOMAT, ZVT, digit span task, dual n-back, PVT) 2-5h after drug intake and the number of self-reported side effects until 5 h after drug intake\n""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charitè-Universitätsmedizin, CBF\nMr. Dr. med. Dimitris Repantis \nEschenallee 3\n14050 Berlin\nGermany"",""Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charitè-Universitätsmedizin, CBF"",""Mr. Dr. med. Dimitris Repantis "",""Eschenallee 3"",""14050 Berlin"",""Germany"",""Telephone: 030 8445 8763\nFax: [---]*\nE-mail: dimitris.repantis at charite.de\nURL: [---]*"",""Telephone: 030 8445 8763"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: dimitris.repantis at charite.de"",""E-mail:"",""dimitris.repantis at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charitè-Universitätsmedizin, CBF\nMr. Dr. med. Dimitris Repantis \nEschenallee 3\n14050 Berlin\nGermany"",""Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charitè-Universitätsmedizin, CBF"",""Mr. Dr. med. Dimitris Repantis "",""Eschenallee 3"",""14050 Berlin"",""Germany"",""Telephone: 030 8445 8763\nFax: [---]*\nE-mail: dimitris.repantis at charite.de\nURL: [---]*"",""Telephone: 030 8445 8763"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: dimitris.repantis at charite.de"",""E-mail:"",""dimitris.repantis at charite.de"",""URL: [---]*"",""URL:""]"
DRKS00005219,2,2,2014-04-17,"Recruiting complete, follow-up complete",2013-08-09,2014-03-31,48,Actual,18 Years,35 Years,Male,"[""Additional Inclusion Criteria"",""- Men\n- 18 - 35 years\n- Written consent (according to AMG § 40 (1) 3b)\n- Good knowledge of German\n- right-handedness\n""]","[""Exclusion Criteria"",""- Known hypersensitivity to the study medication\n- All contraindications to the study medication: arrhythmia, hyperthyroidism , glaucoma , pheochromocytoma , congestive heart failure , diabetes mellitus, known liver and kidney dysfunction, vascular disease , angina, haemodynamically significant congenital heart disease , cardiomyopathy , myocardial infarction, channelopathies, arterial hypertension , cerebrovascular diseases , such as cerebral aneurysm , vascular abnormalities , including vasculitis and stroke.\n- Participation in other clinical trials during or within one month prior to this clinical trial\n- Medical or psychological circumstances that may endanger the proper conduct of the trial\n- Existing serious somatic diseases, even if they are not covered by the contraindications according to product information\n- Existing psychiatric disorders and psychiatric disorders in prehistory\n- Smoker or ex-smoker for less than 5 years\n- Regular caffeine consumption > 4 cups per day\n- Subjects with irregular day -night rhythm (eg shift workers )\n- Unwillingness to the storage and disclosure of pseudonymous data as part of the clinical trial\n- Accommodation in an institution by court or administrative order (according to AMG § 40 (1) 4 )\n- MR contraindications ( eg pacemakers , metallic or electronic implants , metallic splinters , tinnitus, surgical clips )\n""]","[""Resting state Parameters from fMRI- ReHo (regional homogeneity) and ALFF (amplitude of low frequency fluctuation)- to be messured once, 1h after drug intake""]","[""Performance in neuropsychological testing (BOMAT, ZVT, digit span task, dual n-back, PVT) 2-5h after drug intake and the number of self-reported side effects until 5 h after drug intake\n""]","[""Primary Sponsor"",""Charité Campus Charité Mitte\nCharitéplatz 1\n10117 Berlin\nGermany"",""Charité Campus Charité Mitte"",""Charitéplatz 1"",""10117 Berlin"",""Germany"",""Telephone: [---]*\nFax: [---]*\nE-mail: [---]*\nURL: http://www.charite.de"",""Telephone: [---]*"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: [---]*"",""E-mail:"",""URL: http://www.charite.de"",""URL:"",""http://www.charite.de"",""Contact for Scientific Queries"",""Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charitè-Universitätsmedizin, CBF\nMr. Dr. med. Dimitris Repantis \nEschenallee 3\n14050 Berlin\nGermany"",""Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charitè-Universitätsmedizin, CBF"",""Mr. Dr. med. Dimitris Repantis "",""Eschenallee 3"",""14050 Berlin"",""Germany"",""Telephone: 030 8445 8763\nFax: [---]*\nE-mail: dimitris.repantis at charite.de\nURL: [---]*"",""Telephone: 030 8445 8763"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: dimitris.repantis at charite.de"",""E-mail:"",""dimitris.repantis at charite.de"",""URL: [---]*"",""URL:"",""Contact for Public Queries"",""Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charitè-Universitätsmedizin, CBF\nMr. Dr. med. Dimitris Repantis \nEschenallee 3\n14050 Berlin\nGermany"",""Klinik und Hochschulambulanz für Psychiatrie und Psychotherapie, Charitè-Universitätsmedizin, CBF"",""Mr. Dr. med. Dimitris Repantis "",""Eschenallee 3"",""14050 Berlin"",""Germany"",""Telephone: 030 8445 8763\nFax: [---]*\nE-mail: dimitris.repantis at charite.de\nURL: [---]*"",""Telephone: 030 8445 8763"",""Telephone:"",""Fax: [---]*"",""Fax:"",""E-mail: dimitris.repantis at charite.de"",""E-mail:"",""dimitris.repantis at charite.de"",""URL: [---]*"",""URL:""]"
